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SUMMARY
This investigation was designed to characterise the surface components, 
namely the OMPs and LPS, of P. haemolytica and to further the current 
understanding of the role of these components in the pathogenesis of P. 
haemolytica infections.
Initially, OMP and LPS profiles of 29 P. haemolytica  isolates were 
examined and compared by SDS-PAGE and Western blotting. The isolates used 
were o f known serotype, had a known origin and were from a host whose disease 
status was known. Eight distinct OMP profiles and three LPS profiles were 
demonstrated within this population of isolates. An association was found between 
certain OMP types, LPS types, species of origin and disease status of the host. 
Thus, the results demonstrated variation in OMP and LPS profiles and provided 
evidence that these differences may be useful in epidemiological studies of P. 
haemolytica.
A 39.5 kDa outer-membrane protein of P. haemolytica was shown to be 
heat-modifiable and was identified in all P. haemolytica isolates examined. The 
protein occurred in one of two molecular-weight forms depending on the 
solubilisation temperature used, and thus resembled the Omp A protein of E. coli. 
Western blot analysis, using a rabbit monospecific antiserum to the P. haemolytica
39.5 kDa protein, indicated a serological cross-reactivity with the Omp A protein 
and N-teiminal amino acid sequence analysis of the P. haemolytica protein also 
indicated a close homology between these proteins.
The property of serum resistance in 22 P. haemolytica isolates and its 
possible correlation with known surface components was also investigated. 
Isolates were defined as being serum resistant, partially serum sensitive or serum 
sensitive, based on the % survivor value obtained in the serum bactericidal assays. 
Of the 22 isolates examined, 7 isolates proved resistant to serum killing, 6 were 
highly serum sensitive and the remaining 9 isolates were partially serum sensitive. 
Although a relationship between smooth-type LPS and serum resistance was 
identified, there was no correlation of OMP type or capsular type with resistance
to serum killing.
In vivo studies of P. haemolytica included virulence tests on 7 isolates and 
in vivo growth in intraperitoneal implant chambers. The virulence tests involved 
intratracheal inoculation of calves with approximately 10^^ cfu diluted in sterile 
PBS and, after 3 days, expressing the virulence as a lung lesion score. Three of the 
7 isolates produced virtually no lesions while the remaining 4 produced lesion 
scores ranging from 1.7 to 40.5. Comparison of the virulence of the isolates in 
relation to their LPS type, serum resistance and leukotoxin activity suggested that 
although leukotoxin production is important, the other factors also play a part in 
the virulence of P. haemolytica.
To supplement the in vitro studies of P. haemolytica in this investigation, 
in v/vo-grown cells were examined. Studies on bacteria placed within a 
intraperitoneal implant chambers showed a steady decline in numbers over the 16 
day period of the experiment. The reason for this decline, was not determined 
although preliminary experiments indicated the absence of an antibody and 
complement-mediated mechanism of killing within the chamber. The possible role 
of a cell-mediated killing mechanism is a potential area for further investigation. 
Although the bacterial numbers declined inside the chamber, an adequate number 
were recovered for OMP analysis. Differences were found between in vivo and in 
v/fm-grown bacterial cells with respect to OMPs. These findings highlight the 
importance of considering in vivo studies of bacteria when investigating virulence 
determinants and their role in the pathogenesis of bacterial infections.
In summary, this study has provided important infoimation relating the 
surface components of P. haemolytica to the virulence of this species and points to 
the need for further studies of these components as possible protective antigens 
against P. haemolytica infections.
1. INTRODUCTION
1.1 PASTEURELLA HAEMOLYTICA  - HISTORICAL INTRODUCTION
Pasteurella haemolytica is a member of the family Pasteurellaceae, a 
family consisting of three genera, namely Pasteurella, Haemophilus and 
Actinobacillus (Mannheim, 1984). The members of this family have been 
recognized as important pathogens of both animals and man since very early in the 
history of medical bacteriology (Zinnemann, 1981).
During the period 1880-1900, organisms which were later identified as 
members of the genus Pasteurella were first isolated. Louis Pasteur in 1880 was 
the first to identify an organism of this type when he isolated the causative agent of 
fowl cholera, a serious disease of his time. In 1885, Kitt isolated similar organisms 
from other host species, including cattle, horses and pigs, and the name 
"septicaemia haemorrhagia" was proposed by Huppe in 1886 to include all of these 
bacteria. However, in the following, year the name Pasteurella was given to this 
group of organisms by Trevisan, in commemoration of the early work of Louis 
Pasteur (Mannheim, 1984; Carter, 1981).
Further characterisation of this genus led to the identification and 
classification of different species (Mannheim, 1984; Carter, 1981) from a wide 
spectrum of vertebrate hosts, each causing different clinical syndromes. The 
period of 1950-1960s saw the most significant advances in research of Pasteurellas 
and the advancements made both during this period and more recently have been 
extensively reviewed (Carter, 1981; Mannheim, 1984; Wilkie & Shewen, 1988; 
Biberstein, 1990; Woolcock, 1993).
1.2 NATURE OF THE PATHOGEN
1.2.1 Bacteriological characteristics
The principal characteristics of members of the genus Pasteurella are: 
small, Gram-negative rods or coccobacilli, non-motile, facultatively anaerobic, 
catalase and oxidase positive, fermentative producing acid but no gas from a 
number of carbohydrates (Mannheim, 1984; Carter, 1981).
Like other Pasteurella species, P. haemolytica grows well on blood agar 
between 25^C and 40^C with the optimum temperature being 37^C (Mannheim,
1984). Selective media have been described (Morris, 1958; Weissman, 1966) for 
this organism but they are generally not used in routine laboratory work due to the 
ease with which the bacterium grows on complex media. The colonies on blood 
agar are surrounded by a zone of beta-haemolysis, a distinctive property of 
P.haemolytica in comparison to the oi\\tr Pasteurella species (Carter, 1981).
Preservation of P. haemolytica in the lyophilised state using conventional 
suspending media or storage for long periods at -70°C is possible, as for all 
Pasteurella species.
1.2.2 Taxonomy of the organism
Two main approaches have been utilized in defining the species P. 
haemolytica. Firstly, the biochemical and cultural properties have been used 
(Smith, 1961) to distinguish two main biotypes within the species, namely biotypes 
A and T representing arabinose and trehalose fermenting isolates, respectively. In 
Table 1, other differential characteristics often used to distinguish the biotypes are 
listed.
Bio types A and T may be distinguished by their colonial morphology, their
Table 1. Differential characteristics of P. haemolytica  biotypes
CHARACTERISTIC BIOTYPE 
A T
CARBOHYDRATE FERMENTATION
Arabinose + -
Trehalose - +
COI.ONIAL MORPHOLOGY small, grey large, dark brown
GROW TH CURVE die out rapidly survive longer
PENICILLIN SENSITIVITY sensitive resistant
LOCALISATION IN 
NORMAL HOST
nasopharynx tonsils
PRINCIPAL DISEASE -pneumonia in -septicaemia in
ASSOCIATION cattle and sheep 
-septicaemia in 
newborn lambs
lambs > 3 mth
Adapted from Biberstein (1978)
growth cuiwes and also their susceptibility to penicillin (Smith, 1961). However 
these characteristics do not always provide clear-cut differences and thus 
carbohydrate fermentation tests have been relied on most heavily for the sub­
division of the bio types.
More recently, it has been proposed that the A and T biotypes actually be 
regarded as distinct species. Sneath and Stevens (1990), based on the data from 
numerical taxonomic studies, suggested that biotype T isolates of P. haemolytica 
be renamed Pasteurella treha losi.
Smith (1961) found an association of each biotype with different disease 
syndromes in a variety of host species. For example, isolates of the T biotype tend 
to be associated with septicaemia in feeder lambs while those of the A biotype are 
the predominant isolates from pneumonic sheep and calves. The finding that A 
biotype isolates were also more frequently found in the nasopharyngeal carrier 
state than the T biotypes (Smith, 1961) led Biberstein and Thompson (1966) to 
suggest that biotype T isolates, being less frequent and extremely rare in healthy 
animals, and more often associated with clinical disease, have a greater pathogenic 
potential and a lesser ability to adapt to the commensal state. Hence, these early 
investigations, sub-dividing the species into biotypes, provided important 
information for future research on this species.
In addition to two distinguishable biotypes within this species, a second 
scheme, based on the antigenic composition of individual isolates was developed 
by Biberstein et aL (1960) and led to the serotypic classification of this species. 
The technique was initially based on soluble, presumably surface antigens either of 
polysaccharide (Cameron, 1965) or lipopolysaccharide (Carter, 1967; 1975) nature 
and, currently, differentiation of the serotypes, based on the capsular antigen, 
identified using indirect haemagglutination assays (Biberstein, 1978), is the most 
widely practised method of serological classification of P.haemolytica.
To date, 16 serotypes have been identified (Biberstein et a i ,  I960; Fodor et
al., 1988). The work of Biberstein and Gills (1962) investigated the
6
Table 2. Association of biotypes and serotypes of P. haemolytica
UT^
BIOTYPE SEROTYPE
A1 A2 A5 A6 
A A7 AS A9 A ll
A12 A13 A14 A16
T T3 T4 TIO T15
Adapted from Frank (1989) 
lU T  = untypable
distribution of the 16 serotypes among the two biotypes and revealed a distinct
association of certain serotypes with either biotype A or T. Confirmation of this
was seen by Shreeve et a i  (1970). This relationship of biotype to serotype is seen
«Fol.
in Table 2. In addition to these identifiable serotypes, Q u irie^ l986) found that 
10% of P.haemolytica  isolates were untypable by the usual typing mechanisms 
possibly suggesting the presence of a different capsular type on these isolates or 
the absence of a capsule.
It is now understood that certain serotypes are more predominant in certain 
hosts and cause different clinical syndromes, as discussed by Biberstein (1978) and 
De Alwis (1993). For example, isolates of serotype A1 tend to be the predominant 
isolates from septicaemic young lambs and especially from cases of epidemic 
pneumonia in cattle (Fox et a i ,  1971; Frank & Smith, 1983), whereas serotype A2 
isolates appear to be associated mainly with pneumonia in sheep and other 
ruminants (De Alwis, 1993).
From the preceding information it is evident that sub-division of P. 
haemolytica into biotypes and serotypes is important with respect to 
epidemiological and virulence studies. However, in other bacterial species the sub­
division does not stop at serotypes and many investigators in this field have found 
that isolates within a certain serotype of a bacterial species may be further sub­
divided into "sub-types" based on various characteristics of the isolates. For 
example, outer-membrane protein (OMP) and /or lipopolysaccharide (LPS) 
profiles obtained by sodium dodecyl sulphate-polyacrylamide gel electrophoresis 
(SDS-PAGE) have often been utilised. Such "sub-typing" schemes can be found in 
many Gram-negative species including Escherichia coli (Achtman et al ., 1983), 
Haemophilus influenzae (Loeb & Smith, 1980), Actinobacillus pleuropneumoniae 
(Rapp et al ., 1986) and Pasteurella multocida (Lugtenberg et al .,1984). With 
this in mind, the possibility exists of using such schemes for the typing of P. 
haemolytica isolates and requires further investigation.
1.3 PATHOGENESIS OF BOVINE PNEUMONIC PASTEURELLOSIS
1.3.1 Clinical disease
Pasteurella haemolytica is an important pathogen causing pneumonia and 
systemic infections primarily in sheep and cattle (Biberstein & Thompson, 1966; 
Wessman & Hilker, 1968) although similar organisms have been isolated from 
other non-ruminant hosts (Biberstein et al., 1960).
Pneumonic pasteurellosis of sheep and cattle is caused by P. haemolytica 
isolates of biotype A. In sheep, the predominant isolates associated with 
pneumonic pasteurellosis are of serotype A2, whereas in calves serotype A l is the 
predominant serotype (Frank, 1989). Pasteurella haemolytica biotype T isolates 
{P. trehalosi) are associated with systemic pasteurellosis of sheep, a disease less 
common on a worldwide scale than pneumonic pasteurellosis, but still a major 
concern in Britain (Gilmour, 1993). A common feature in all these disease 
syndromes is the occurence of asymptomatic carriers of the bacterium, which play 
an important role in the pathogenesis of the disease. Pathogenesis is apparently 
multifactorial in nature, involving other factors besides bacterial infection (Gilmour 
& Gilmour, 1989; Gilmour, 1993).
Pneumonic pasteurellosis is the most economically important disease 
caused by P. haemolytica. In North America this respiratory disease in calves is 
referred to as "shipping fever" while in Europe "transit fever" is the term more 
commonly used to describe it (Frank, 1989). Both these teims refer to the 
association of bacterial infections with the rearing procedures of the calves in 
causing pneumonic pasteurellosis. The disease is believed to involve various factors 
such as stress or viral infection in addition to P. haemolytica infection (Jensen et 
al, 1976; Frank, 1986; 1989; Wilkie & Shewen, 1988) and, based on this
multifactorial aetiology, is often referred to as a “disease complex”. However, it is
generally thought that P. haemolytica infection is the major factor in pneumonic
9
pasteurellosis and previous investigators (Friend et al., 1977; Gibbs et al., 1984; 
Ames et al., 1985), have reported the production of pneumonic pasteurellosis 
experimentally in normal animals by infection with P. haemolytica alone.
1.3.2 Carrier state in cattle
Pasteurella haemolytica A l is often carried in the nasopharynx and is also 
found in the tracheal air of healthy calves. However, since the numbers present 
comprise only a small proportion of the bacterial flora it is difficult to detect their 
presence (Grey & Thomson, 1971; Frank & Smith, 1983) thus making 
epidemiological studies and control of this disease difficult. These commensal 
bacteria are one of the two sources of P. haemolytica which ultimately causes 
pneumonic pasteurellosis, the other source being passage from infected calves (see 
Figure 1). As yet, the reasons why healthy carriers convert to cases of clinical 
disease remain unknown. However, conditions of stress and viral infections, which 
cause the immune system of the host to become compromised, are considered 
important predisposing factors for the eventual illness caused by P. haemolytica 
(Gilmour, 1993). Some investigators, however have shown P. haemolytica 
serotype A 1 to cause pneumonic pasteurellosis in the absence of such predisposing 
factors (Friend et al, 1977; Newman et al, 1982; Gibbs et al., 1984; Ames et al.,
1985). Thus, the question remains as to the necessity of predisposing factors for 
the development of the clinical disease of pneumonic pasteurellosis.
1.4 VIRULENCE ATTRIBUTES OF THE BACTERIUM
Pasteurella haemolytica, like the other pathogenic members of the family 
Pasteurellaceae, must fulfil a number of pathogenicity requirements in order to
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Figure 1. Pathogenesis of bovine pneumonic pasteurellosis
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Adapted from Frank (1986)
cause disease (Nicolet, 1990). After infection of the host, the bacterium must 
colonize the mucosal surface, survive and multiply, and interfere with the host 
defence mechanisms, before ultimately causing the damage to the host which 
results in clinical disease. The steps leading to pneumonic pasteurellosis in calves 
are seen in Figure 1.
To fulfil all o f these requirements, the bacterium possesses a number of 
virulence factors which are presumed to be involved at the various stages of the 
disease (Biberstein, 1990; Nicolet, 1990). These virulence determinants are either 
surface-associated or produced extiacellularly by the bacterium and are presented 
diagranStically in Figure 2.
1.4.1 Surface structures of the bacterium
1.4.1.1 Fimbriae
Fimbriae of a number of Gram-negative bacteria have been shown to serve 
as adhesins, causing the bacteria to adhere to eukaryotic cell surfaces, namely the 
mucosal surfaces of the host species. Fimbriation of vai'ious members of the 
Pasteurellaceae has been observed - H. influenzae (Guiima et al, 1982), A. 
pleuropneumoniae (Tomak et al, 1988), P. multocida (Trigo & Pijoum, 1988) and 
Actinobacillus actinomycetemcomitans (Scannapieco et al, 1983).
In 1987, Morck et al. demonstrated two types of fimbriae on the surface of 
a P. haemolytica serotype A l isolate grown in vitro, these being a large rigid type 
(lOnm wide) and a smaller flexible type (5nm wide). Support for their presence in 
vivo was later seen in organisms from lung lavage fluid (Morck et al., 1988) and 
also in organisms seen adhering to tracheal epithelial cells (Morck et al, 1989). As 
yet the precise role of fimbriae in the pathogenesis of P. haemolytica  is unknown. 
In the light of the role of fimbriae in other Gram-negative bacteria, they are most
12
Figure 2, Diagrammatic representation of the putative virulence 
determinants of P. haemolytica
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likely to be involved in colonization of the upper respiratory tract (URT), the first 
step in the pathogenesis of the disease.
1.4.1.2 Capsular polysaccharide
The presence of polysaccharide capsules is a common feature among the 
members of the family Pasteurellaceae (Inzana, 1990). These structures confer 
various properties on the bacterium. Firstly, they often form the basis of sub­
division of the bacterial species into serotypes and, in the case of P. haemolytica 
(also including the new species representing biotype T isolates, P. trehalosi) 16 
distinct polysaccharide capsules have so far been identified (Biberstein, 1978; 
Adlam, 1989) representing the 16 serotypes. The second role of the capsule is in 
the pathogenesis of P. haemolytica infection.
In P. haemolytica, the polysaccharide capsule is produced during the 
logarithmic phase of growth and has been visualized in organisms grown in vitro 
(Gilmour et al .,1985) and in vivo (Morck et al, 1988). It is believed to serve as a 
means of attachment to the mucosal epithelial cells during the early stages of 
disease (Morck et al, 1988) and also to inhibit host immune defenses, phagocytosis 
and complement"mediated killing (Chae et a i ,  1990).
The chemical composition of the capsule of a number of the serotypes is 
known (Adlam, 1989) and there appears to be a very close relationship to the 
capsules of other Gram-negative pathogens (Adlam et al., 1984; 1987) not only in 
composition but in virulence properties. For example, the P. haemolytica serotype 
A l capsular polysaccharide structure is similar to the enterobacterial common 
antigen - a polymer of N-acetyl-D-mannosaminuronic acid linked 1-4 to N-acetyl- 
D-glucosamine (Adlam et al., 1984). The polysaccharide caspsule of serotype A2 
isolates is identical to the capsule of Neisseria meningitidis, group B and E.coli 
K l, i.e. colaminic acid (Adlam et ai., 1987).
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1.4.1.3 Lipopolysaccharide (LPS)
Lipopolysaccharide is a prominent surface component of all Gram-negative 
bacteria and constitutes approximately h2-2*5% of the dried cell weight of P. 
haemolytica (Keiss et a l ,  1964).
Structurally, LPS of P, haemolytica is similar to that of other Gram- 
negative bacteria in that it may be composed of three main units:- a lipid A region, 
a core oligosaccharide region and an antigenic polysaccharide chain of repeating 
sugar units (O-antigen repeats). In P. haemolytica, the composition of the LPS, as 
analysed by SDS-PAGE, has been found to differ both between the serotypes 
(Perry & Babuik, 1984; Leitch & Richards, 1988) and even within serotypes 
(Davies et a i ,  1991; Ali et a i ,  1992; Utley et al, 1992; McCluskey et a i ,  in press). 
SDS-PAGE profiles of LPS consist of a series of low-molecular-mass bands which 
represent the lipid A-core oligosaccharide unit and a “ ladder pattern” of high- 
molecular-weight bands representing different numbers of the O-antigen repeats 
linked to the core region of the LPS (Davies et a l ,  1991). Rough-type LPS lacks 
the high-molecular-weight chains, the O-antigen side chains, while smooth-type 
LPS possesses them.
Although all isolates of biotype A were initially thought to possess rough-
type LPS (lacking the O-antigen repeat units) while those of biotype T possess
smooth-type LPS (0-antigens present) (Adlam, 1989), more recent investigations
have demonstrated the presence of O-antigen side chains in some isolates of the A
biotype (Davies et a l ,  1991; Utley et al, 1992; Lacroix et a l ,  1993). By SDS-
PAGE, these workers were able to show the presence of the high-molecular-
weight bands in the profiles of biotype A isolates. Additionally, variation in the
lipid A-core oligosaccharide region has been reported (Davies et a l ,  1991; M i et
a l ,  1992), where the mobilities of the low-molecular-weight bands differed
between isolates of the same or different serotypes. Thus it appears that
microheterogeneity of LPS, as seen in other Gram-negative bacteria, also exists in
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the LPS o f P. haemolytica.
As mentioned in section 1.2.2, this type of variation in LPS is often used as 
the basis of a sub-typing scheme which can be of great value in epidemiological 
and virulence studies of bacterial species (Inzana, 1983; Inzana & Pichichero, 
1984; Achtman et a i ,  1983; Achtman & Plusche, 1986), and suggests the need for 
further investigation o f P. haemolytica LPS.
1.4.1.4 Outer-membrane proteins (OMPs)
Only limited investigations of the outer-membrane proteins of P. 
haemolytica have been carried out and their role in the pathogenesis of P. 
haemolytica infection is still poorly understood. However, analysis of OMPs by 
SDS-PAGE has indicated similarities to those of other Gram-negative bacteria in 
that the outer membrane of P. haemolytica contains approximately 15-20 minor 
proteins and about 4-5 major proteins (Squire et a i ,  1984; Knights et a i ,  1990; 
Davies et a i ,  1992).
The profiles obtained by SDS-PAGE are different between the two 
biotypes A and T (Adlam, 1989; Woolcock, 1993) and to a lesser extent between 
the serotypes (Knights et a i ,  1990) but, until the present study, no variation had 
been reported within the serotypes. Since variation in the OMP profiles has been 
identified within individual serotypes of other bacterial species and often used to 
develop a sub-typing scheme for the species (see section 1.2.2), it was possible that 
similar variation would exist within P. haemolytica populations and was therefore 
an area which required investigation.
As to the actual role o f the OMPs in the pathogenesis o f P. haemolytica,
little is known due to the limited investigations which have been carried out.
However, Donachie and Gilmour (1988) examined the SDS-PAGE OMP profiles
of P. haemolytica serotype A2 isolates and identified the expression of certain
high-molecular-weight proteins in organisms obtained from pleural fluid, which did
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not appear to be expressed by in vitro-grown organisms. Similarly, other 
investigations have examined these high-molecular-weight proteins, namely the 71, 
77 and 100 KDa proteins (Deneer & Potter, 1989; Morck et a i ,  1991; Murray et 
a l ,  1991; Davies et aL, 1992) and have found that increased expression of these 
proteins occurs in vitro when the bacteria are grown under iron-restricted 
conditions. Thus, it is generally thought that these iron-restricted OMPs are 
involved in survival of P. haemolytica in vivo, possibly in the assimilation of iron. 
Similar findings have been observed in E.coli (Finn et al., 1982) and Haemophilus 
ducreyi (Trees et a l ,  1991). Although investigation of the OMPs of P. 
haemolytica has been limited, it does appear that they are generally similar to those 
of other Gram-negative species.
The study of OMPs by SDS-PAGE has demonstrated the property of 
"heat-modiflability" of certain proteins in a number of Gram-negative bacteria 
(Beher et a l ,  1980). This property results in the respective protein being present 
in one of two molecular weight forms depending on the temperature used to 
solubilise the protein sample prior to electrophoresis. The reasoning behind this 
phenomenon has been described in detail previously (Nakamuru & Mizushima, 
1976) and states that at the lower solubilisation temperature the heat-modifiable 
OMP appears at the lower-molecular-weight due to an excess binding of SDS to 
the protein molecule, which is predominantly in the conformation of beta-sheets, 
the excess binding of SDS causing the protein to run faster in the gel. 
Solubilisation of the protein at high temperatures causes a conformational change 
of the protein molecule, such that it exists in the alpha-helical form, which binds 
less SDS causing the protein to run slower in the gel. Consequently, the lower- 
molecular-weight form of the protein is observed with low solubilisation 
temperatures and the higher-molecular weight form is seen when higher 
solubilisation temperatures are applied.
The work of Beher et al. (1984) demonstrated this property for the Omp A
protein of E. coli, and showed similar proteins in other Gram-negative species.
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More recently, in the Pasteurellaceae family, an Omp A-like protein has been 
identified in Haemophilus somnus (Tagawa et al., 1993), H. ducreyi (Spinola et 
a i ,  1993) and A. actinomycetemcomitans (Wilson, 1991) by SDS-PAGE and also 
by amino acid sequence comparisons of the protein with that of E. coli. Until now, 
no such studies have been reported for P. haemolytica .
1.4.2 Extracellular bacterial products
1.4.2.1 Leukotoxin
An extracellular virulence factor produced by some members of the 
Pasteurellaceae is a heat-labile cytotoxin with the ability to lyse leukocytes 
(Nicolet, 1990; Lo, 1990). The leukotoxin of P. haemolytica is target-cell specific 
in that it acts only on ruminant leukocytes (Woolcock, 1993) and has been 
implicated as an important virulence determinant which contributes to the 
pathogenesis of pneumonic pasteurellosis by disrupting the lung defence 
mechanisms and consequently the immune response to the bacterium within the 
lung (Shewen & Wilkie, 1982; Lo, 1990). The toxin is a protein of approximately 
105 KDa (Lo et a i ,  1985; Chang et al., 1986) which shares both structural and 
genetic sequence homology to the alpha-haemolysin of E. coli (Strathdee & Lo, 
1987) and also to the other similar toxins which fomi the family of toxins known as 
the RTX toxins (Welch, 1991; Coo te, 1992). The genes involved in the successful 
production and secretion of the toxin from the bacterial cell form an operon with 
four individual genes, a feature common to all the RTX toxins. These four genes 
encode the toxin itself and the proteins involved in its activation and secretion 
(Welch, 1991).
Currently, investigations of the leukotoxin continue, and further
information on and understanding of this protein and its exact role in the
pathogenesis of P. haemolytica infection is likely to become evident in the near
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future.
1.4.2.2 Haemolysin
Surprisingly little information is available on this virulence factor of P. 
haemolytica which gives rise to the species name, even after 30 years of research. 
It is known that this bacterial product is not encoded on plasmid DNA like similar 
products of other bacteria (Chang et al,, 1987) but its role as a virulence factor is 
not clear. A recent report (Forestier & Welch, 1990) suggested that the 
haemolysin of P. haemolytica may be identical with the leukotoxin, although, 
confirmation of this is required.
1.4.2.3 Neuraminidase
Neuraminidase production in P. haemolytica was first demonstrated by 
Scharmann et al. (1970) and was later confirmed by Frank and Tabatabai (1981). 
This virulence factor is not common to the other members of the family 
Pasteurellaceae (Nicolet, 1990) although a neuraminidase has been shown to be 
produced by P. multocida isolates (Scharmann et al, 1970). Its role in 
pathogenesis is not fully understood but, as neuraminidases are present in other 
bacterial pathogens which are able to survive on mucosal surfaces (Adlam, 1989), 
it may reduce the protective bai'rier effect of epithelial mucous membranes of the 
host (Adlam, 1989). Thus, further investigations are obviously required in order to 
fully understand the precise role of this determinant in the virulence of P. 
haemolytica.
1.4.2.4 Protease
A protease specific for sialoglycoproteins was demonstrated by
19
Otulakowski et al. (1983). However, since then, little has been done to 
characterise its role in the pathogenicity of P. haemolytica and further 
investigations are required.
Thus, this section has summarised the bacterial components which possibly 
have a role in the pathogenesis of P. haemolytica infections. Although some of 
these determinants have attracted great interest, namely the capsule, LPS and 
leukotoxin, other components, paiticularly the OMPs, should not be disregarded in 
future studies, as most researchers in this field believe that a successful vaccine 
against this pathogen will consist of a number of different components of the 
bacterium, including the surface proteins.
1.5 P A STE U R E LLA  H A E M O LYTIC A  - IN  VIVO
As is evident from the information given in section 1.4 regarding the 
virulence determinants of the bacterium, most of what is currently known relates to 
organisms grown in vitro, although a few studies discuss in v/vo-grown organisms 
(Donachie & Gilmour, 1988; Morck et al, 1988; 1989; 1991; Sutherland et al., 
1991; C onférera /., 1992;).
The necessity of studying organisms grown in vivo relates to the variation 
which may occur in the expression of bacterial products or virulence determinants 
under in vivo growth (Brown & Williams, 1985; Brown et al., 1988). This 
variation is of major importance when bacterial components, which may be 
susceptible to variation, are actually being considered as vaccine candidates 
(Brown et al., 1988).
Bacteria from lung lavage fluid of chronically-diseased calves have been
used in the investigations by Morck et al., (1988,1989) while Donachie & Gilmour
(1988) in addition used organisms isolated from pleural fluid as representatives of
in v/va-grown organisms. Organisms obtained from chambers implanted into the
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peritoneal cavity o f rabbits (Morck et al., 1991) and also chambers implanted 
subcutaneously into the flanks of calves (Confer et al., 1992) were examined. 
These studies generally reported variation in certain properties, especially in SDS- 
PAGE OMP profiles, between in vivo and in vitro grown organisms, and the 
expression o f certain high-molecular-weight OMPs (descibed previously - section 
1.4.1.4). Investigations of this kind have been reported in other bacterial species 
such as E. coli (Finn et al., 1982), H. ducreyi (Trees et a i ,  1991), and 
Pseudomonas aeruginosa (Kelly et al., 1987; 1989) where implanted chambers 
were used for obtaining in vivo-grown cells (Pike et al., 1991; Day et al., 1980). 
Until the present study, however, there has been only two reports of such 
examinations in P. haemolytica (Morck et a i ,  1991; Confer et a i ,  1992).
1.6 H O ST IM M U N E R ESPO N SE AGAINST P. H A E M O LYTIC A
Although pneumonic pasteurellosis is thought of as a multifactorial disease, 
many researchers in this field believe that control of P. haemolytica infection 
would result in a significant decrease in the severity and prevalence of the disease 
and the economic losses caused by it (Confer et al., 1988; Roth, 1988; Mosier 
1993). Thus a detailed understanding of the immune mechanisms which enhance 
immunity to P. haemolytica and a knowledge of the important bacterial antigens 
which stimulate these mechanisms is required before a more efficacious vaccine can 
be developed.
As with other bacterial infections, more than one immune mechanism may
be involved in producing resistance to infection. The most widely studied
mechanism is the humoral immune response, which involves a number of complex
interactions. Humoral immunity against P. haemolytica involves production of
antibodies to specific surface components of the bacterium in addition to
leukotoxin-specific antibodies (Confer et al., 1987; Gentry et a i ,  1988). Such
antibodies to surface components of other Gram-negative bacteria have often been
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associated with resistance to further infection (Winter, 1979; Gilleland & 
Matthewsgreer, 1987). The antibodies produced may have several potential 
actions, namely, inhibition of attachment and colonization, agglutination and 
opsonisation of the bacterial cells to enhance phagocytosis, neutralization of 
leukotoxin activity and, activation of the classical complement pathway by binding 
to bacterial surface components (Roth, 1988; Confer et al, 1988). However, as 
yet, the important protective antigens of P. haemolytica have still to be defined.
The host cell-mediated immune response, involving T-lymphocytes which 
can act directly on the bacterial cell or enhance macrophage killing of intracellular 
bacteria (Confer et aL, 1988) is an important protective mechanism of a number of 
hosts, although little research has been documented to characterise this particular 
response to P. haemolytica. However, as the cell-mediated immune response 
enhances the function of alveolar macrophages in the lung and also neuuophil 
activity (Roth, 1988; Czuprinski & Sample, 1990) it is likely that induction of cell- 
mediated immunity would be beneficial to the P. haemolytica- infected host.
1.6.1 Bactericidal action of host serum against P. haemolytica
The bactericidal activity of serum against Gram-negative bacteria, including 
P. haemolytica, is generally believed to represent an important defence mechanism 
of the host. This subject has been extensively studied and reviewed in the last 
decade (Taylor, 1983, 1988; Joiner ef a/., 1984; Crokaert a/., 1992).
The bactericidal activity of serum is largely due to the complement system, 
a series of proteins which, when activated by one of two pathways, form a 
membrane-attack complex capable of inserting into the outer membrane of Gram- 
negative bacteria causing cell lysis to occur (Taylor, 1983; Frank et a i ,  1987). 
When activated by antigen-anti body complexes the pathway is referred to as the 
Classical complement pathway whereas activation in the absence of antibody
represents the Alternative complement pathway. This latter pathway may be
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activated by a number of substances including bacterial cell wall constituents 
(Taylor, 1983). Consequently, the ability of bacterial cells to resist killing by the 
complement system is a major detemiinant of pathogenicity and has been identified 
in many Gram-negative species including A, pleuropneumoniae (Rycroft & Cullen, 
1990), Neisseria  species (Schneider et a l ,  1982; Schneider, 1985) and E. coli 
(Kim et al., 1986; Cross et a i ,  1986). The actual mechanism responsible for this 
resistance has been extensively studied and is thought to have a multifactorial basis 
involving bacterial components such as capsular polysaccharides 
(Kim et al., 1986; Cross et al., 1986), LPS (Cross et al., 1986; Grossman et al., 
1987; Merino et al., 1992) and OMPs (Blaser et al., 1987; Weiser & Gotschlich, 
1990).
Currently, the studies of bactericidal activity of serum against P. 
haemolytica have been limited (MacDonald et al., 1983; Sutherland, 1988). These 
reports have shown that isolates of P. haemolytica may be susceptible to killing by 
adult bovine serum or lung washings from infected sheep by antibody and 
complement. However the exact reason for the sensitivity of individual isolates to 
this bactericidal effect remains unknown and thus future investigations are required 
to enable us to understand the importance of this defence mechanism in combating 
P. haemolytica infection and also the role of serum resistance in the pathogenicity 
of the bacterium.
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OBJECT OF RESEARCH
The overall aim o f this investigation was to provide a greater understanding 
of the species Pasteurella haemolytica with particular emphasis on the surface 
components of the organism and their possible role in virulence. The study was 
divided into five distinct areas, although they were all designed to contribute to 
fulfilling the aim described above. Each section involved unique investigations 
which had not previously been performed with this species. The five main sections 
were entitled:
(1) An epidemiological study of P. haemolytica',
(2) Characterisation of a heat-modifiable outer-membrane-protein in 
P. haemolytica',
(3) Serum sensitivity in relation to surface properties;
(4) Virulence tests in calves;
(5) Investigations of P. haemolytica grown in vivo.
Section (1) involved analysis of OMPs and LPS o f 29 P. haemolytica 
isolates by SDS-PAGE and Western blotting. The types identified with these 
techniques were then compaied with the other known details of each isolate.
A heat-modifiable OMP of P. haemolytica was identified by SDS-PAGE in 
section (2) of this study. Further analysis involving Western blotting and N- 
terminal amino acid comparisons was performed to investigate the degree of 
relatedness of this protein with heat-modifiable proteins in other bacteria.
In section (3) the serum sensitivity of 22 P. haemolytica  isolates was 
assessed using a serum killing assay. The results were assessed in relation to the 
serotype and LPS type of the isolates in an attempt to correlate serum resistance or 
sensitivity with surface properties.
The final two sections of this investigation involved examinations of this
species in vivo . Virulence tests were the basis of section (4). The tests involved
2 4
intratrachael inoculation of calves with the bacteria and scoring the number of lung 
lesions produced after three days. The lung lesion score was taken as a measure of 
virulence and related to the other known properties of the isolate. In the last 
section (5), four P. haemolytica strains were placed within intraperitoneal implant 
chambers and their viability determined at intervals. The OMP profiles of the in 
vivc>“grown bacteria were compared with those of in vitro-grown cells.
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2. MATERIALS AND METHODS
2.1 BACTERIAL STRAINS
A total of 39 P. haemolytica isolates and one E.coli strain, Lilly, were 
used. The P. haemolytica isolates comprised 24 of serotype A l, 14 of serotype A2 
and 1 untypable isolate. Further information regarding the date of isolation, farms 
of origin and disease status of the host can be found in Tables 3 and 4.
2.2 GROWTH CONDITIONS
After primary isolation, isolates were stored at -70^C in brain heart infusion 
broth (BHIB; Oxoid) containing 50% glycerol. They were subcultured routinely at 
37°C on brain heart infusion agar (BHIA; Oxoid) containing 5% sheep's blood.
2.2,1 Growth of P. haemolytica for OMP preparations
Bacteria were grown overnight at 37^C  in 25 ml volumes of BHIB, with 
shaking at 120 rpm, and 1 ml of these cultures were used to inoculate 500 ml 
volumes of fresh BHIB, which was incubated under the above conditions, until late 
logarithmic phase (approximately 6-7 h; see Figure 3). At this point the cells were 
harvested by centrifugation at 9000 x g for 30 min and used for OMP preparations 
as described in section 2.3. Purity checks were carried out on all cultures used for 
OMP preparations by inoculating 0.1 ml from the 500 ml culture onto BHIA 
(containing 5% defibrinated sheep blood), incubating them overnight at 37^0  and 
observing the purity of the growth as judged by the colony morphology.
In some cases the bacteria were required to be gi’own under conditions of 
iron limitation to obtain expression of the iron-regulated proteins (Davies et ai., 
1992). For this, the iron chelator ethylenediamine dihydroxy phenyl-acetic acid
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Table 3. Pasteurella haemolytica isolates used in this study
Strain
designation ^
Date of 
isolation
Site of 
isolation^
Disease status Serotype
P H 2  ( S C 8 2 /1 ) - L R T D IS E A S E D A l
P H 4  ( G A 8 3 /5 ) - L R T D IS E A S E D A l
P H 8  (V 9 6 5 B ) - L D IS E A S E D A l
P H 4 8  ( F A l ) - L D IS E A S E D A l
P H 1 6 2 2 .8 4 L D IS E A S E D A l
P H  164 1 2 .8 4 L D IS E A S E D A l
P H  16 6 1 2 .8 4 L D IS E A S E D A l
P H 1 6 8 1 0 .8 2 L D IS E A S E D A l
P H  17 0 1 1 .8 2 L D IS E A S E D A l
P H 1 7 2 1 1 .8 3 L D IS E A S E D A l
P H  174 1 1 .8 3 L D IS E A S E D A l
P H 2 2 0 - L D IS E A S E D A l
P H 2 6  (G A 8 3 /1 ) - N P H E A L T H Y A l
P H 3 0  (W D 8 3 /4 ) - N P H E A L T H Y A l
P H I  7 6 2 .8 4 N P H E A L T H Y A l
P H 1 7 8 2 .8 4 N P H E A L T H Y A t
P H  18 0 2 .8 4 N P H E A L T H Y A l
P H  18 2 2 .8 5 N P H E A L T H Y A l
P H  184 2 .8 5 N P H E A L T H Y A l
P H 1 8 6 2 .8 5 N P H E A L T H Y A l
P H 1 8 8 2 .8 5 N P H E A L T H Y A l
P H  190 2 .8 5 N P H E A L T H Y A l
P H 1 9 2 2 .8 5 N P H E A L T H Y A l
P H  194 2 .8 5 N P H E A L T H Y A l
P H 4 2 _ L D IS E A S E D A 2
P H 7 2  (B 6 6 4 ) - L D IS E A S E D A 2
P H 1 9 6 1 2 .8 4 L D IS E A S E D A 2
P H  198 1 2 .8 4 L D IS E A S E D A 2
P H 2 0 0 1 2 .8 4 L D IS E A S E D A 2
P H 2 0 2 1 2 .8 4 L D IS E A S E D A 2
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Table 3. continued.
P H 2 0 4 1 2 .8 4 L D IS E A S E D A 2
P H 4 4  (G T 8 5 /1 5 ) - N P H E A L T H Y A 2
P H 2 0 8 1 .8 5 N P H E A L T H Y A 2
P H 2 1 0 1 .8 5 N P H E A L T H Y A 2
P H 2 1 2 1 .8 5 N P H E A L T H Y A 2
P H 2 1 4 3 .8 5 N P H E A L T H Y A 2
P H 2 1 6 3 .8 5 N P H E A L T H Y A 2
P H 2 1 8 3 .8 5 N P H E A L T H Y A 2
U T 3 - L D IS E A S E D U T
^Strain designations used by other workers are given in brackets.
^  L R T  =  l o w e r  r e s p i r a t o r y  t r a c t ;  L = l u n g ;  NP = n a s o p h a r y n x .
All isolates were provided by D. H. A. Gibbs (Glasgow University Veterinary
School)with the exception isolates PH8, PH48, PH72 and UT3, which were
obtained from Dr. W. Donachie (Moredun Research Institute).
All isolates were of bovine origin except isolates PH8, PH48 and PH72, which
were of ovine origin
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Figure 3. Typical growth curve of P. haemolytica (isolate PH176) in BHIB
Pasteurella haemolytica was grown in 25 ml of BHIB at 37®C, with shaking, for 
9h and the OD660 was recorded at intervals.
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(Sigma) was added to the 500 ml of BHIB at an optimal concentration for 
expression of the respective proteins but also to allow suitable growth of the 
bacteria. Typical growth curves of the bacterium (isolate PH2) in BHIB containing 
different EDDA concentration are shown in Figure 4. The concentration chosen 
was that which inhibited growth (as a result of iron-limitation) to some extent when 
compared to the control , but which yielded sufficient cell numbers to allow for 
OMP preparation. Thus, in this experiment a concentration o f 20yw.M EDDA was 
chosen.
2.2.2 Growth of P. haemolytica for serum bactericidal tests
For the serum bactericidal tests, described in detail in section 2.9, bacteria 
were grown in 25 ml of BHIB at 37*^C, with shaking at 120 rpm, until mid- 
logarithmic phase (approximately 4-5 h - see Figure 3) then harvested by 
centrifugation at 3,000 x g for 15 min.
2.2.3 Growth of E, coli for cross-absorbing antiserum
Monospecific anti serum against the heat-modifiable OMP of P. haemolytica 
(as described in section 2.5.2) was cross-absorbed with E. coli Lilly. E. coli was 
grown in 500 ml of BHIB at 37°C, with shaking, until mid-logarithmic phase then 
harvested by centrifugation at 9,000 x g for 30 min. The cells obtained were used 
for cross-absorbing, as described in section 2.5.3.
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Figure 4. Growth of P. haemolytica (isolate PH2) in BHIB containing 
different concentrations of EDDA
Growth curves obtained as described in the legend to Figure 3, except that filter- 
sterilised EDDA was added to the media at the concentrations indicated in the 
figure. Growth of the bacterium in BHIB alone was included as a control.
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2.2.4 Growth o f P. haemolytica  for chamber inoculations
For in vivo studies, an intraperitoneal implant chamber was used as described in 
section 2.11. P. haemolytica isolates PH2, PH30, PH42, and PH48 were used for 
inoculating the chambers. These were grown in 500 ml of BHIB at 37*^C with 
shaking, until late-logarithmic phase (approximately 6-7 h; see Figure 3) then 
harvested as described in section 2.11. Purity checks were performed on all 
cultures prior to harvesting.
2.2.5 Growth of P. haemolytica  for virulence tests in cattle
Pasteurella haemolytica isolate PH2 was used for standardisation of the 
virulence tests, described in detail in section 2.10. Bacteria were grown in 500 ml 
of BHIB at 37^C with shaking, until late logarithmic phase, and then haiwested as 
described in section 2.10.
The isolates being compared for virulence (PH2, PH8, PH 10, PH30, PH42 
PH44 and PH72) were grown as described above. Purity checks were carried out 
as usual.
2.3 PREPARATION OF OUTER-IVIEMBRANE FRACTIONS
The outer-membrane fractions of the isolates were obtained by Sarkosyl 
extraction using the method described by Davies et al., 1991. After growth of the 
cells as described in section 2.2,1, they were harvested by centrifugation at 10,000 
X g for 30 min, washed in 20 ml of 20 mM Tris-hydrochloride buffer (pH7.2) and 
finally resuspended in 10 ml of the same buffer. The cells were disrupted, on ice, 
by sonication continuously for 10 min (MSB sonicator, 4 - 5^m amplitude, 20kHz). 
Unbroken cells were removed by centrifugation at 10,000 x g for 30 min at 4^C
and the total cell envelope pelleted by centrifugation at 50,000 x g for 60 min at
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4^C. The inner-membrane fraction was solubilised by resuspending the pellet in 
0.5% (w/v) sodium lauroyl sarcosine (Sarkosyl) for approximately 30 min at room 
temperature (Filip et a l ,  1973) and the insoluble outer-membrane fraction was 
obtained by centrifugation at 50,000 x g for 60 min at 4^C. The outer-membrane 
fraction was washed in 20 mM Tris-hydrochloride buffer (pH7.2)^ centrifuged 
at 50,000 X g for 60 min at 4^C, resuspended in the same buffer to a protein 
concentration of 2.0 mg/ml, and stored at -20°C.
The procedure used for obtaining outer-membrane fractions from the in 
vivo -grown cells was identical to the above except that the initial cell number was 
lower and consequently the final amount of protein obtained was less. Outer- 
membrane fractions from isolates obtained from lung washings were provided by 
Dr. R. L. Davies and used in section 2.11.4. The method for obtaining OMP 
fractions from the bacteria was essentially as described above.
2.3.1 Quantitation of protein
The protein concentration for each outer-membrane fraction was 
determined using the modified I.owry procedure of Mark well et al. (1978). A 
standard curve of ug protein/ml (using bovine serum albumin (BSA; Sigma) as the 
standard) versus optical density at 610 nm was obtained (see Figure 5) and used for 
determining the protein concentration of each outer-membrane sample.
2.3.2 Solubilisation of protein
After the outer-membrane fraction was adjusted to a protein concentration of 2 
mg/ml with 20 mM Tris-hydrochloride (pH7.2), a chosen volume was diluted in an
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Figure 5. Standard curve for determining protein concentrations of outer- 
membrane preparations
The method of Mai’kwell et a i  (1978) was used with bovine serum albumin (BSA) 
as the standard protein, and the cui*ve opposite was used to determine the protein 
concentration in each outer-membrane preparation.
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equal volume of x 2 sample buffer (see Appendix 1) and solubilised by heating at 
100°C for 5 min.
2.3.3 Effect of different solubilisation temperatures on SDS-PAGE profiles
In section 3.2 the heat modifiability of certain P. haemolytica proteins was 
examined. Outer-membrane fractions were treated at different temperatures - room 
temperature, 5()®C, 60°C, 70^C, 85®C and lOO^C, usually for 5 min. In some 
experiments, the time of solubilisation was extended to 10 or 20 min. All samples 
were stored at -20^C.
2.4 PREPARATION OF LPS FRACTIONS
2.4.1 Proteinase K digestion of outer-membrane fractions
To obtain LPS fractions for analysis by SDS-PAGE, outer-membrane 
fractions were digested with proteinase K as described previously by Davies et at., 
1991. Ten micro litres of proteinase K (Sigma - adjusted to 2.5 mg/ml in x 1 sample 
buffer - see Appendix 1) were added to 100 ul of solubilised outer-membrane 
fraction (100 ug protein) and the mixture heated for 60 min at 60^C. All samples 
were stored at -20^C.
2.5 ANTISERA PRODUCTION
For this part of the study, the animal work, i.e.the inoculation and bleeding 
of the animals, was performed by Drs. H. A. Gibbs (Department of Veterinary 
Medicine, University of Glasgow) and R. L. Davies (Department of Microbiology, 
University of Glasgow).
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2.5.1 Anti whole-cell sera
Two antisera to P. haemolytica whole cells were used in this study, namely 
antisera 32 and 10. Antiserum 32, a convalescent bovine serum raised against P. 
haemolytica isolate PH2, was provided by Dr. Q. All (PhD Thesis, 1993). 
Production of this antiserum involved experimental intratracheal infection of a calf 
with live cells, as described by Gibbs et aL (1984). Antiserum 10, a hyperimmune 
bovine serum raised against isolate PH2 was provided by Dr. R. L. Davies and 
produced by an initial intramuscular injection of a calf with formalin-killed 
organisms mixed with Freund's incomplete adjuvant (FIA; Difco) and an additional 
subcutaneous injection after a period of 27 days.
2.5.2 Anti-OM P antisera
Attempts were made to raise rabbit monospecific anti-OMP antibodies to 
the protein indicated by the arrow in Figure 6. The reasons for choosing this 
specific protein will become evident later.
The OMP sample of isolate PH2 was subjected to electrophoresis as 
described in section 2.6, except that a preparation gel was used instead of the usual 
15 well gel (i.e. one large well of a single sample, resulting in complete strips of the 
individual proteins across the whole gel). The gel was stained for 5 min using 
Coomassie blue and destained for no more than 20 min to enable the appropriate 
protein band to become visible. The acidity of the gel (due to the acetic acid in the 
staining reagents) was neutralised by washing in PBS (pH7.2), to which was added
1.0 M sodium hydioxide (NaOH) until the pH stabilised at 7. The inoculum was 
prepared by excising the strip containing the appropriate band from the gel, 
crushing the gel in 1 ml of sterile PBS and mixing with 1 ml of Freund’s complete 
adjuvant (FCA; Difco) for the initial intramusculai* inoculation or 1 ml Freund’s
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Figure 6. DiagraiÆ tic representation of the OMP profile of PH2
A simplified representation of the OMP profile of P. haemolytica isolate PH2 as 
visualised on a SDS-polyacrylamide gel or after Western blotting on a Problott 
membrane after staining with Coomassie blue stain. The protein excised was used 
in sections 2.5.2 and 2.8 of this study.
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incomplete adjuvant (FIA) for subsequent subcutaneous inoculations. This 2 ml 
antigen/adjuvant mixture was injected into a New Zealand rabbit at four different 
sites. The antibody response to the protein was monitored by Western Blotting and 
the procedure tenninated when a significant response was observed. The antiserum 
obtained was stored at -20^C.
2.5.3 Cross-absorption of antiserum
The rabbit anti-OMP serum was cross-absorbed with E. coli Lilly (see 
section 3.2.3). The bacterial cells used for cross-absorption were grown as 
described in section 2.2.3 and harvested by centrifugation at 9,000 x g for 30 min. 
Bacterial cells pelleted from 100 ml of BHIB cultures were resuspended in a 5 ml 
mixture of anti serum diluted in PBS (pH7.2) at a ratio of 1:5. The mixture was 
incubated at 37^C, with rotating, for 1 h, after which the bacterial cells were 
removed by centrifugation at 3,000 x g for 15 min, leaving the cross-absorbed 
anti serum. This procedure was repeated twice more to ensure complete
absorption.
2.6 SDS-PAGE
OMPs (prepared as described in section 2.3) were separated by SDS-PAGE 
using the SDS discontinuous system of Laemmli (1970) as described by Davies et 
a i ,  1992. Briefly, 20 ul (20 ug protein) of protein sample were loaded into each 
well (or 450 ul into one well in the case of a preparation gel) of a 4% (w/v) 
acrylamide stacking gel and separated in a 12% (w/v) acrylamide resolving gel (see 
Appendix 1). Electrophoresis was carried out in a vertical slab gel apparatus 
(Protean II; Bio Rad) in buffer comprising 25 mM Tris-hydrochloride, 192 mM 
glycine and 0.1% (w/v) SDS (pH 8.3), at a constant current of 20 mA per gel
through the stacking gel and 30 mA per gel through the resolving gel.
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Molecular weight standards (Pharmacia) used were phosphorylase b (94 
KDa), bovine serum albumin (67 KDa), ovalbumin (43 KDa), carbonic anhydrase 
(30 KDa), trypsin inhibitor (20.1 KDa), and alpha-lactalbumin (14.4 KDa). 
Proteins were visualised by staining overnight with 0.1% (w/v) Coomassie Brilliant 
Blue (Sigma) in 10% (v/v) acetic acid and 45% (v/v) methanol in deionised water, 
and destaining for approximately 5 h with several changes of the destaining solution 
(ee Appendix 1).
The apparent molecular weights of individual proteins were estimated from 
a calibration curve of Rf values (distance travelled by protein band from top of the 
gel/distance from top to the bottom of the gel) plotted against the logjo molecular 
weight of the standard proteins (Figure 7). Thus, by calculating the Rf value of the 
unknown protein and by interpolation on the standard curve, the apparent 
molecular weight could be obtained.
LPS samples (prepared as described in section 2.4.1) were analysed 
essentially as for OMPs with the exception that the resolving gel contained 15% 
(w/v) acrylamide and 4 M Urea (Davies et aL, 1991) - see Appendix 1. Five 
microlitres of the proteinase K-treated sample (approximately 5 ug LPS) were 
loaded per well and the separated LPS visualised by silver staining (Appendix 2) as 
described by Tsai & Frasch (1982).
2.7 W ESTER N  B LO TTIN G
Western blotting was performed as described previously (Davies et al., 
1994. OMPs and LPS were transferred to nitrocellulose (Schleicher & Schuell) in a 
Bio-Rad Trans-Blot Cell with plate electrodes (Bio-Rad, Richmond, CA 94804) 
following the manufacturer's instructions. Transfer of OMPs was carried out 
overnight at a constant voltage of 15 V in a buffer containing 25 mM
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Figure 7. Standard curve for estimating the apparent molecular weights of 
individual proteins in SDS-PAGE profiles
The log 10 MW of each of the standard proteins phosphorylase b (94 KDa), bovine 
serum albumin (67 KDa), ovalbumin (43 KDa), carbonic anhydrase (30 KDa), 
trypsin inhibitor (20.1 KDa), and alpha-lactalbumin (14.4 KDa) were plotted 
against the Rf value for the protein i.e. the distance travelled by the protein band 
from the top of the gel/the distance from the top to the bottom of the gel, to obtain 
the calibration curve opposite. By calculating the Rf value o f any protein band and 
interpolation on this curve, the apparent molecular weight of the protein was 
obtained.
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Tris-HCl, 192 mM glycine (pH 8.3). LPS was transferred similarly but in a buffer 
with the addition of 20% (v/v) methanol. After transfer, the blotting membranes 
were washed in 20 mM Tris-hydrochloride, 500 mM sodium chloride buffer , pH
7.5 (TBS), for 5 min. Non-specific binding was blocked by incubation for 1 h in 
TBS containing 3% (w/v) gelatin (Bio Rad). The nitrocellulose membranes were 
washed (two 5 min washes) in 0.05% (v/v) Tween 20 (Sigma) in TBS (TTBS) and 
incubated overnight in primary antibody diluted 1 in 200 in 1% (w/v) gelatin in 
TTBS (antibody buffer). After two 5 min washes in TTBS, the membranes were 
incubated for 4 h with horseradish peroxidase-conjugated anti-rabbit or -bovine IgG 
antibodies diluted 1 in 2000 in antibody buffer. The membranes were washed in 
TTBS (two 5 min washes) followed by one wash in TBS (5 min) and developed in 
substrate solution. The substrate solution for OMPs contained 0.05% (w/v) 4- 
chloro-l-naphthol (Sigma) (dissolved in 20 ml ice-cold methanol) and 0.05% (v/v) 
hydrogen peroxide in 100 ml of TBS, while that for LPS contained 0.025% (w/v) 
diamino benzoic acid (DAB; Aldrich) dissolved in 100 ml PBS, 2% (v/v) cobalt 
chloride and 0.05%. Development was stopped by immersing the nitrocellulose in 
deionised water for 10 min. The transfer efficiency for OMPs was tested by 
staining a section o f the membrane with 0.1% (w/v) amido black (Sigma). All 
reagents used in Western blotting are given in Appendix 3.
Different primary antibodies were used in the different sections of this 
study. Bovine antiserum 32 was used in sections 3.1.1 and 3.2.3; rabbit anti-OMP 
antiserum was used also in sections 3.2.3 and 3.2.4. The horseradish peroxidase- 
conjugates (SEROTEC) were specific for either bovine or rabbit IgG antibodies 
depending on the source of the primary antibody used.
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2,8 PROTEIN SEQUENCING
N-terminal amino acid sequencing was performed for a particular P. 
haemolytica outer-membrane protein, was performed. Tricine SDS-PAGE was 
used for preparing the protein samples for N-terminal sequencing, according to the 
method provided by Dr. M. Cusack (Department of Geology and Applied Geology, 
University of Glasgow).
This procedure was essentially the same as SDS-PAGE with a few 
alterations: the stacking gel contained 4 % acrylamide and the resolving gel 10 % 
acrylamide (Appendix 1); electrophoresis was performed overnight (using the same 
apparatus as previously) in a cathode buffer containing 0.1 M Tris, 0.1 M Tricine 
and 0.1% (w/v) SDS and an anode buffer containing 0.2 M Tris-HCl (pH8.9) 
(Appendix 1), at a constant current of 20 mA. OMPs were then transferred from 
tricine polyaciylamide gels to a Problott membrane (Applied Bio systems) as 
described in section 2.7, with a few alterations. Transfer was carried out overnight 
at a constant voltage of 20 V in a buffer containing 10 mM 3 - [cyclohexylamino] - 
1 - propane sulfonic acid (CAPS; Sigma) adjusted to pH 11 with 1 M sodium 
hydroxide (NaOH). After ti'ansfer, the Problott was washed briefly in milliQ water, 
stained with 0.1% (w/v) Coomassie Brilliant Blue R-250 (Sigma) in 10% (v/v) 
acetic acid and 45% (v/v) methanol in mihi Q water for 1 min, destained with 50% 
(v/v) methanol and washed once more in milli Q water. The protein band to be 
sequenced (see Figure 6), having been identified by brief staining with Coomassie 
blue stain, was excised from the membrane.
The sequencing was carried out by Dr. M. Cusack (Department of Geology 
and Applied Geology, University of Glasgow) using an ABI 477A pulse-liquid 
protein sequencer and an ABI 420-H amino acid analyser. Computer printouts and 
interpretations of the sequence were provided.
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2.9 SERUM  BACTERICIDAL ASSAYS
2.9.1 Assay procedure
Initially, optimal conditions for the demonstration of bactericidal activity 
were determined with respect to serum concentration, bacterial inoculum size and 
incubation period of the reaction. These initial results are given in section 3.3.1.
The assay was an adaptation of the method of Davies (1991) and was 
performed in 96-well, tissue culture-grade, U-bottomed microti ter plates 
(Dynatech) into which 180 ul of diluent (PBS, pH7.2) was delivered into 8 wells 
with a multi-channel pipette. The reaction mixture was set up, on ice, and 
contained 10 ul of bacterial cells and 90 ul of serum or, in some assays, a greater 
total volume with the same overall ratio of cells and serum. The reaction mixture 
was incubated at 37®C for the required incubation period. At time 0 h, (or any 
other time at which the viable cell numbers was to be determined) two 20 ul 
volumes were removed from each reaction mixture, loaded into the first two wells 
of the micro titer plate and serially-diluted (1 in 10) using a multi-channel pipette 
through 6 wells. Twenty microlitres from each well were inoculated onto BHIA 
containing 5% defibrinated sheep's blood and incubated overnight at 37®C. The 
mean cfu ml"^ for each assay was calculated from each duplicated count. The 
percentage of bacterial inoculum remaining after the incubation period, i.e. % 
survivors, was calculated using the formula: mean cfu ml"^ after incubation / mean 
cfu ml"^ before incubation x 100.
2.9.2 Serum bactericidal activity against P. haemolytica
A number of P. haemolytica isolates, representing those possessing
different capsular, OMP and LPS types, were examined for serum sensitivity or
resistance. The assay was performed as described above using bovine
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hyperimmune antiserum 10 raised against isolate PH2 (see section 2.5.1). P. 
haemolytica isolate PH8 and E.coli LÜly were used as controls, since both were 
known to be serum sensitive. Decomplementation of the serum by heating at 56°C 
for 30 min was also used as a negative control. The definitions of serum resistance 
or sensitivity were based on the percentage of survivors where a value of >100 % 
survivors represented serum resistance, a value < 0.1 % survivors represented 
serum sensitivity and a value of 0.1*~99.9 % survivors represented partial serum 
sensitivity.
All sera used for screening the isolates was stored at ~70^C in aliquots to 
maintain complement activity.
2.10 VIRULENCE TESTS IN CALVES
The virulence tests were in collaboration with Dr. H. A. Gibbs (Department 
of Veterinary Medicine, University of Glasgow). The tests involved intratracheal 
inoculation of the calves which were then sacrificed after three days and the lungs 
removed for lung scoring.
2.10.1 Standardisation of virulence tests
Standardisation of these tests, prior to screening different P. haemolytica 
isolates, involved 21 calves divided into 7 groups of 3. Variables in each group 
were the size of the bacterial inoculum and the diluent used. Two of the groups 
were contr ol groups, receiving one of the diluents alone.
P . haemolytica isolate PH2 was grown as described in section 2.2.5 in 4 x
500 ml BHIB broth cultures and pooled together prior to inoculum preparation. In
order to vary the cell numbers of the inocula, the volume of bacterial culture used
for the initial harvesting differed between the groups: 25 ml, 250 ml, and 1150 ml
were used to provide low, medium and high inocula, respectively. Cells were
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harvested by centrifugation at 9,000 x g for 30 min and resuspended in 20 ml of 
either sterilised PBS or filter-sterilised (Acrodisc, 0 .2 ^m ) culture supernate. Two 
control groups of PBS or culture supernate alone were included in this 
standarisation process.
2.10.2 Comparison of virulence of various isolates
The virulence tests involved 4 calves per isolate tested, these being PH2, 
PH30, PH 10, PH8, PH42, PH44 and PH72. Each isolate was grown as described 
in section 2.2.5. Two 500 ml cultures of each isolate were pooled together, mixed 
and dispensed into 4 x 250 ml volumes (representing the medium inoculum size - 
see previous section). After harvesting by centrifugation at 9,000 x g for 30 min, 
the cell pellets were resuspended in a total volume of 20 ml of sterile PBS to 
produce the final inocula. Calves were inoculated intratracheally as described 
previously.
Determination of the virulence of the individual isolates involved lung 
scoring in addition to assessment of various physiological factors throughout the 
experiments. This work was carried out by Dr. H. A. Gibbs who provided a 
tabulated fonn of the results, as seen in section 3.4.
2.11 IN VIVO STUDIES OF PASTEURELLA HAEMOLYTICA
2.11,1 Intraperitoneal implant chambers in calves
Chambers implanted into a number of different animals have been used as a 
means of obtaining in y/vr;-grown bacterial cells. Bacteria obtained from such a 
system were examined in this work. The chamber was designed by Dr. R. L. 
Davies (Department of Microbiology, University of Glasgow) and the operations to
insert the chamber intraperitoneally into the calves were performed by Dr. H. A.
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Gibbs. The chamber was essentially a modification of that described by Pike et a l  
(1991), an external sampling port which allowed continuous sampling. More 
details of both the design and the insertion of the chambers will be given elsewhere. 
My involvement in this work was in preparing the bacterial inocula for the 
chambers and in processing the chamber fluid and organisms obtained.
2.11.2 Preparation of inocula and sampling of the chamber
After insertion, the chambers, whi^ch had an internal volume of 
approximately 100 ml, were filled with PBS then left for 3 days to allow host 
peritoneal fluid to diffuse into the chamber. The bacterial isolates to be examined 
were then inoculated into the chambers.
P. haemolytica isolates PH2, PH30, PH42, and PH48 were grown as 
described in section 2.2.4 and harvested by centrifugation at 9,000 x g for 30 min. 
Cells were resuspended in PBS (pH7.2) to an OD610 of 1.0, representing 
approximately 10^ cfu/ml. Inoculation of 1 ml of this cell suspension into the 
chamber, resulted in a initial concentration of approximately 10^ cfu/ml in the 
chamber. Viable counts were performed to confirm the actual numbers of cells 
inoculated and to check the purity of the cultures.
At daily intervals, 2-3 ml samples were removed from the chamber and 
bacterial counts were determined. Samples of filter-sterilised fluid removed from 
the chamber were stored at -70°C.
2.11.3 Effect of chamber fluid on in v///*o-grown P. haemolytica
The effect of chamber fluid on the viability of in v/fro-grown cells was
assessed. P. haemolytica isolates PH2, PH30, PH42 and PH48 were grown in 25
ml of BHIB at 37^C, with shaking at 120 rpm, for approximately 4 h, after which
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they were harvested and resuspended to an OD610 of 1.0 which contained 
approximately 10^ cfu/ml. Fifteen microlitres of each suspension were inoculated 
into 1 3 5 of  homologous chamber fluid, i.e., fluid in which the same isolate had 
been growing in vivo . Cell viability in this fluid was examined over a period of 2 h 
by performing bacterial counts in duplicate and the % survivor value calculated as 
described in section 2.9. The in vitro growth of the bacteria was assessed in 
chamber fluid removed at days 0, 9 and 16 of the experiment. The antibody 
content o f the chamber fluids was also examined by Western blot analysis using P. 
haemolytica OMPs as target antigens.
2.11.4 OMP preparations from in v/vo-grown cells
Outer-membranes from the in vivo -grown cells were obtained essentially as 
described in section 2.3, On the day prior to removal of the chamber from the calf, 
a 5 ml cell suspension (containing 10^^ cfu/ml) was inoculated into the chamber. 
The following day the chamber was removed and the fluid collected and centrifuged 
at 9,000 X g for 30 min to pellet the cells for outer-membrane preparations.
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3. RESULTS
3.1 AN EPIDEMIOLOGICAL STUDY OF PASTEURELLA  
HAEMOLYTICA
In this investigation, SDS-PAGE and Western blotting were used to 
demonstrate variation in OMP and LPS profiles of 29 P. haemolytica isolates, 18 
of serotype A1 and 11 of serotype A2. The variation observed enabled the division 
of these isolates into distinct groups possessing different OMP and LPS types. In 
addition, information on the disease status of the host from which the isolates were 
obtained, and the origin of each isolate, were also known and considered.
3.1.1 Identification of different OMP profiles in P. haemolytica
The OMP profiles of serotypes A1 and A2 of P. haemolytica, as visualised 
by Coomassie blue staining, consisted of three or four major proteins and 
approximately 1 5 - 2 0  minor proteins (Figure 8). The profiles of both serotypes 
were very similar but not identical. There were a number of differences, 
particularly in the minor proteins, although the mobility of the upper major protein 
was different between the serotypes. These differences are indicated by the 
arrrows in Figure 8. The OMP profiles observed within the 18 serotype A1 
isolates were very similar when examined by Coomassie blue staining and could 
not readily be distinguished (Figure 9a), while the profiles of the 11 serotype A2 
isolates, as seen on the Coomassie blue-stained gels, could be distinguished more 
readily on the basis of variation in the mobilities of individual proteins (Figure 9b). 
Differences in the mobilities of the high molecular weight proteins were observed 
between serotype A2 isolates PH 196, PH198 and PH200 (lanes 1-3, arrows), 
isolates PH202 and PH204 (lanes 4 and 5, arrows) and isolate PH214 (lane 9, 
upper arrows). This latter isolate also differed from the others in the mobility of
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Figure 8. Typical OMP profiles of P. haemolytica  serotypes A l and A2 
obtained by SDS-PAGE analysis
Coomassie blue-stained SDS-PAGE OMP profiles of P. haemolytica isolates of 
serotype A l (PH 188) and serotype A2 (PH210), in lanes 1 and 2, respectively. 
Arrows indicate the differences in OMP profiles (see text). Molecular weight 
standards (kDa) are shown in lane 3.
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Figure 9a. SDS-PAGE OMP profiles of P. haemolytica isolates of serotype A l
Coomassie blue-stained SDS-PAGE OMP profiles of P. haemolytica seroytpe A l 
disease isolate, PH 162 (OMP type 1.1), P H I64 and P H I66 (OMP type 1.2), PH 
168 and P H I70 (OMP type 1.3), and PH172 and P H I74 (OMP type 1.2), and 
non-disease isolates PH180 and P H I84 (OMP type 1.2) and PH176, PH178 and 
P H I82 (OMP type 1.4), in lanes 1-12, respectively. Molecular weight standards 
(kDa) are shown in lane 13.
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Figure 9b. SDS-PAGE OMP profiles of P. haemolytica isolates of serotype 
k l
Coomassie blue-stained SDS-PAGE OMP profiles of P . haemolytica serotype A2 
disease isolates PH 196, PH198 and PH200 (OMP type 2.1), and PH202 and 
PH204 (OMP type 2.2) and non-disease isolates PH212, PH210 and PH208 (OMP 
type 2.3), PH214 (OMP type 2.4) and PH216 and PH218 (OMP type 2.2), in lanes 
1-11, respectively. Arrows indicate differences in OMP profiles (see text). 
Molecular weight standards (kDa) are shown in lane 12.
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the upper major protein (lanes 8 and 9, lower arrows). Thus, within each of the 
serotypes, particularly serotype A1 it was difficult to distinguish between individual 
OMP types by Coomassie blue-staining. However, by supplementing these results 
with those fi'om Western blotting, variation was more clearly evident and the OMP 
types could be distinguished.
W estern blotting with bovine convalescent serum 32 identified differences 
within the serotype A1 isolates which had previously been unrecognised and also 
more clearly differentiated the isolates of serotype A2. These differences, 
identified by Western blotting, enabled four distinct OMP types to be distinguished 
in each of the serotypes. Within the 18 serotype A1 isolates, the OMP types were 
designated OMP types 1.1, 1.2, 1.3, and 1.4 and these differed in the 
immunological recognition of various minor proteins (Figure 10a, indicated by 
anow s). The 11 A2 isolates also consisted of four distinct OMP types, 2.1, 2.2,
2.3 and 2.4 (indicated in Figure 10b). Again, this variation was based on 
differences in the immunological recognition of various minor proteins as indicated 
by the arrows (lanes 4, 6 and 9). In OMP type 2.1 a wider range of proteins, in 
addition to a high background staining were recognised. Thus, based mainly on 
the Western blotting results, four individual OMP types could be distinguished in 
each of the serotypes.
3.1.2 Identification of different LPS profiles in P. haemolytica
The LPS SDS-PAGE profiles of P. haemolytica serotypes A1 and A2
exists in either the smooth or rough form, depending on the presence or absence of
0-antigen side-chains, respectively (Davies et a l ., 1991; Ali et a i ,  1992). The O-
antigen side-chains are seen as a series of high-molecular-weight bands which form
a ladder pattern (Davies et a L ,\9 9 \). In previous studies, the presence of two
smooth and three rough LPS types (types 1, 2 and 3, 4 or 5, respectively) in
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Figure 10a. Western blot showing the antibody recognition patterns of
bovine antiserum 32 against the OMPs of P. haemolytica A1 isolates
Western blot showing the reaction of a 1 in 200 dilution of bovine antiserum 32 
against the OMPs of P. haemolytica serotype A1 disease isolates P H I62 (OMP 
type 1.1), PH 164 and PH 166 (OMP type 1.2), PH168 and PH170 (OMP type
1.3), PH172 and PH 174 (OMP 1.2), and non-disease isolates PH 180 and PH174 
(OMP type 1.2), and PH176, PH178 and PH 182 (OMP type 1.4), in lanes 1-12, 
respectively. Approximate molecular weights (kDa) indicated on the right. OMP 
types are indicated along the bottom; arrows indicate differences between OMP 
types (see text).
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Figure 10b Western blot showing the antibody recognition patterns of
bovine antiserum 32 against the OMPs of P, haemolytica A2 isolates
Western blot showing the reaction of a 1 in 200 dilution of bovine antiserum 32 
against the OMPs of P. haemolytica serotype A2 disease isolates PH 196, P H I98 
and PH200 (OMP type 2.1) and PH202 and PH204 (OMP type 2.2), and non­
disease isolates PH212, PH210 and PH208 (OMP type 2.3), PH214 (OMP type
2.4) and PH216 and PH218 (OMP type 2.2), in lanes 1-11, respectively. 
Approximate molecular weights (kDa) are indicated on right. OMP types are 
indicated along the bottom. Arrows indicate differences between OMP types (see 
text).
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serotypes A l and A2 isolates have been described (All et a i ,  1992). The LPS 
profiles identified in this study were compared with those previously described and 
were demonstrated as either LPS types 1, 3 or 5 (Figure 11).
Within the 18 serotype A1 isolates, only one LPS profile was identified. 
This was a smooth type LPS, type 1 (Figure 11, lanes 2 and 3). The isolates of 
serotype A2 consisted of one of two rough LPS types, type 3 or 5. These differed 
from each other in the mobilities of the low-molecular-weight bands which 
represent the core-oligosaccharide region. LPS type 3 was found in three isolates 
(Figure 11, lanes 6 and 7), whereas the remaining 8 isolates possessed LPS type 5 
(Figure 11, lanes 10 and 11). The variation in the low-molecular-weight bands is 
indicated by arrows (lanes 6 and 7).
3.1,3 Relationship of disease status of the host, the geographical location and 
date of the isolation with OMP and LPS types
Infomiation regarding the disease status of the host from which the isolate 
was obtained, the geographical location where the isolation was made and the date 
of the isolation, was available for each isolate. The relationship of these to 
serotype, OMP type and LPS type is shown in Table 4.
Serotype A1 disease isolates, all of which possessed LPS type 1, were
obtained from faims 1, 2, 3 and 4 and could be differentiated on the basis of their
OMP types, i.e. types 1.1, 1.2 or 1.3. Serotype A1 non-disease isolates, all of
which possessed LPS type 1, were obtained from fami 5 and the majority were of
OMP type 1.4. Two isolates were of OMP type 1.2. The situation was more
complex within the serotype A2 isolates because two different LPS types were
present, i.e. types 3 and 5. Isolates of OMP type 2.1 were associated only with
LPS type 3; the remaining isolates possessed LPS type 5 but could be distinguished
by having one of three different OMP types, i.e. types 2.2, 2.3, or 2.4. Serotype
A2 disease isolates were obtained from farm 6 and formed two
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Figure 11. SDS-PAGE LPS profiles of P. haemolytica isolates
Silver-stained SDS polyacrylamide gels comparing the LPS profiles of P. 
haemolytica isolates used in the present study (isolates P H I88, PH 190, PH196, 
PH 198, PH204 and PH208) with those of the 5 previously described LPS types 
(isolates PH2, PH30, PH8, B664, and PH44). Isolates and LPS types are as 
follows: PH2, PH 188 and PH 190 (LPS type 1), PH30 (LPS type 2), PH8, PH 196 
and PH 198 (LPS type 3), B664 (LPS type 4), and PH44, PH204 and PH208 (LPS 
type 5), in lanes L I  1, respectively. Arrows indicate the O-antigen side chains in 
LPS type 1.
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Table 4. Comparison of serotype, OMP type, LPS type for each P. haemolytica 
isolate with the origin of the isolate and the disease status of the host
Laboratory Date of  Origin of isolate  Disease status Serotype OMP LPS
designation isolation Location ^  Site of isolation^ of host type type
P H 1 6 2 2 .8 4 1 L P N E U M O N IC A 1 1.1
P H  16 4 1 2 .8 4 2 L P N E U M O N IC A 1 1.2
P H 1 6 6 1 2 .8 4 2 L P N E U M O N IC A 1 1.2
P H 1 6 8 1 0 .8 2 3 L P N E U M O N IC A 1 1.3
P H 1 7 0 1 1 .8 2 3 L P N E U M O N IC A 1 1.3
P H 1 7 2 1 1 .8 3 4 L P N E U M O N IC A 1 1.2
P H 1 7 4 1 1 .8 3 4 L P N E U M O N IC A 1 1 .2
P H 2 2 0 NK^ N K 3 L P N E U M O N IC A 1 1 .2
P H  17 6 2 .8 5 5 N P H E A L T H Y A I 1 .4
P H 1 7 8 2 .8 5 5 N P H E A L T H Y A l 1 .4
P H  18 0 2 .8 5 5 N P H E A L T H Y A l 1.2
P H 1 8 2 2 .8 5 5 N P H E A L T H Y A l 1 .4
P H 1 8 4 2 .8 5 5 N P H E A L T H Y A l 1.2
P H I  8 6 2 .8 5 5 N P H E A L T H Y A l 1 .4
P H 1 8 8 2 .8 5 5 N P H E A L T H Y A l 1 .4
P H I  9 0 2 .8 5 5 N P H E A L T H Y A l 1 .4
P H I  9 2 2 .8 5 5 N P H E A L T H Y A l 1 .4
P H  1 9 4 2 .8 5 5 N P H E A L T H Y A l 1 .4
P H 1 9 6 1 2 .8 4 6 L P N E U M O N IC A 2 2.1 3
P H 1 9 8 1 2 .8 4 6 L P N E U M O N IC A 2 2.1 3
P H 2 0 0 1 2 .8 4 6 L P N E U M O N IC A 2 2.1 3
P H 2 0 2 1 2 .8 4 6 L P N E U M O N IC A 2 2 .2 5
P H 2 0 4 1 2 .8 4 6 L P N E U M O N IC A 2 2 .2 5
P H 2 0 8 1 .85 5 N P H E A L T H Y A 2 2 .3 5
P H 2 1 0 1 .85 5 N P H E A L T H Y A 2 2 .3 5
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Table 4. continued.
P H 2 1 2 1 .8 5 5 N P H E A L T H Y A 2 2 .3 5
P H 2 1 4 3 .8 5 5 N P H E A L T H Y A 2 2 .4 5
P H 2 1 6 3 .8 5 5 N P H E A L T H Y A 2 2 .2 5
P H 2 1 8 3 .8 5 5 N P H E A L T H Y A 2 2 .2 5
^ 1 -6  indicate the different farms the isolates originated from. 
^ L = lung, NP = nasopharynx 
3 NK ~ not known
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groups which could be cleaiiy distinguished by both their OMP and LPS types, i.e. 
OMP/LPS types 2.1/3 and 2.2/5. Serotype A2 non-disease isolates were obtained 
from farm 5. They were all of LPS type 5 and could be differentiated by their 
OMP types, i.e. types 2.2, 2.3 or 2.4. When serotype A1 and A2 isolates from 
farm 5 were considered together, at least 5 groups of isolates were present, 
i.e.OMP/LPS types 1.2/1, 1.4/1, 2.2/5, 2.3/5 and 2.4/5. However , these isolates 
were obtained on three separate occasions (1.85, 2.85 and 3.85) and, as can be 
seen from Table 4, the various OMP/LPS types were isolated on only one of the 
three occasions.
3.2 CHARACTERISATION OF A HEAT-MODIFIABLE OMP IN 
PASTEURELLA HAEMOLYTICA
SDS-PAGE and Western blotting were used in this study to demonstrate 
the presence of a heat-modifiable OMP in P. haemolytica. This property results in 
a change in the apparent molecular weight of a particular protein, as seen on 
stained gels or in immunoblots, when the protein is solubilised at different 
temperatures in sample buffer.
3.2.1 Identification of a heat-modifiable OMP in P. haemolytica
The SDS-PAGE profiles of Sarkosyl-insoluble OMP preparations of P. 
haemolytica isolate P H I88 treated at different solubilisation temperatures and also 
different times, are shown in Figure 12. As the solubilisation temperature was 
increased from room temperature to 5()^C, a protein band of apparent molecular 
weight 40.5 kDa appeared while a lower-molecular-weight protein of disappeared 
(lanes 1 and 2, indicated by arrow). Although this finding suggested that the
5 9
Figure 12. SDS-PAGE OMP profiles of P. haemolytica after solubilisation at
different temperatures
Coomassie blue-stained SDS-PAGE OMP profiles of P. haemolytica isolate 
PH 188 after solubilisation at room temperature, 5()^C, 60^C, 1(PC, 85®C 
andlOO^C for 5 min (lanes 1-5, respectively), and lOO^C for 10 and 20 min (lanes 
6 and 7, respectively). Arrows indicate differences between profiles at different 
solubilisation temperatures (see text). Molecular weight standards (kDa) are 
shown in lane 8.
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lower-molecular-weight protein, after solubilisation at 50^C, appeared at the 
higher-molecular-weight position, this required confirmation, especially since this 
heat modifiablity at the lower temperatures does not appear to have been reported 
with other Gram-negative species. However, as in other species, a heat-modifiable 
protein of approximately 30-40 kDa appeared after solubilisation temperatrures of 
lOO^C. As the solubilisation temperature is increased from 85^0  to lOO^C (lanes 
4 and 5) a protein band of apparent molecular weight 39.5 kDa becomes evident 
with a decrease in a band of 31 kDa. This shift from 31 kDa to 39.5 kDa is 
observed more clearly in lanes 6 and 7, where the OMP samples were solubilised at 
lOO^C for 10 and 20 min instead of the usual 5 min. Confirmation of this shift was 
made by excising from the gel the lower-molecular-weight band from a sample 
solubilised at room temperature, re-solubilising the band at lOO^C for 5 rain and 
finally re-examining it on an SDS-polyaciylamide gel (results not shown). 
Solubilisation of the excised low-molecular-weight 31 kDa protein at lOO^C 
caused it to appear at the higher molecular weight when re-examined. Thus, P. 
haemolytica appears to possess a 39.5 kDa protein which is heat-modifiable, 
characteristically shifting from a low to high-molecular-weight at lOO^C. This 
finding was also confiimed by Western blotting with a monospecific anti serum 
raised against the high-molecular-weight foim of the protein (described in section 
2.5.2). The results obtained are described below and shown in Figures 16 and 17.
Since heat-modifiable OMPs have been described in other Gram-negative 
bacteria, including Escherichia coli (Beher et a i ,  1980), the findings reported in 
this study for P. haemolytica were compared with those seen in E. coli. In Figure 
13, the SDS-PAGE profiles of Sarkosyl-insoluble OMP preparations of E. coli, 
solubilised at different temperatures are shown. Comparison of these profiles 
shows the appearance of the characteristic porin proteins of E. coli (in the 
molecular weight range of 30-43 kDa), at solubilisation temperatures of 60^C and
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Figure 13. SDS-PAGE OMP profiles of E.coli after solubilisation at different
temperatures
Coomassie blue-stained SDS-PAGE profiles of E. coli after solubilisation at room 
temperature, 50^C, 60^C, 70^C, 85^C and lOO^C for 5 min in lanes 1-6, 
respectively. Arrows indicate differences in profiles at different temperatures (see 
text). Molecular weight standards (kDa) are shown in lane 7.
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above. The disappeai'ance of a high-molecular-weight protein and appearance of 
the upper major protein (Figure 13, lane 3; lower arrow), after solubilisation at 
60^C possibly represents the peptidoglycan-associated-protein of E. coli (Beher et 
aL, 1980), although confirmation of this is required. The heat-modifiable OMP of 
E. coli was present in the high molecular weight form following solubilisation 
temperatures of 70^C and above (Figure 13, lanes 4-6, indicated by the arrows) 
and this is in contrast to the heat-modifiable protein of P. haemolytica which 
appeared in the high-molecular-weight form only after solubilisation at lOO^C. The 
apparent molecular weights of the high- and low-molecular-weight foiins of the 
heat-modifiable protein of E. coli also differ from those of the P. haemolytica 
protein, those of the former being 30 and 33 kDa in comparison to 31 and 39.5 
kDa in P. haemolytica. The heat-modifiable proteins of both these species me also 
compared in section 3.2.4.
3.2.2 The presence of a heat-modifiable OMP in P. haemolytica  serotypes A1 
and A2
The occurrence of a heat-modifiable OMP in 9 P. haemolytica isolates, 
representing both serotypes A1 and A2 (4 isolates and 5 isolates, respectively), 
was demonstrated by SDS-PAGE (results not shown). Representative profiles of 
the OMPs from an A1 isolate, P H I88, and an A2 isolate, PH210 (lanes 1-6 and 7- 
12, respectively), solubilised at different temperatures, are shown in Figure 14. In 
lanes 6 and 12, the heat-modifiable OMP, following solubilisation at lOO^C for 20 
min is indicated by the arrows. The change in apparent molecular weight took 
place between 85°C and lOO^C. This finding was common to all 9 isolates 
examined in this study.
6 3
Figure 14 . SDS-PAGE OMP profiles of P. haemolytica isolates of serotypes 
A l and A2 after solubilisation at different temperatures
Coomassie blue-stained OMP profiles of P. haemolytica isolates P H I88 (serotype 
A l) and PH210 (serotype A2), lanes 1-6 and 7-12, respectively, after solubilisation 
at room temperature (lanes 1 and 7), 50°C (lanes 2 and 8), 60°C (lanes 3 and 9), 
70°C  (lanes 4 and 10), and 85°C (lanes 5 andl 1 ) for 5 min and 100°C (lanes 6 and 
12) for 20 min. Arrows indicate the heat-modifiable OMP (see text). Molecular 
weight standards (kDa) are shown in lane 13.
64
1 2  3  4 5  6  7 8 9  10 1 1 1 2  13
— 94 
^ 6 7
* t e 4 3  
,30
14 4
3.2.3 Immunogenicity of the heat-modifiable OMP
3.2.3.1 Analysis with bovine convalescent antiserum
To deteiTnine the immunogenicity of the heat-modifiable OMP in either of 
the two molecular weight forms, serum obtained after experimental infection of a 
calf with whole cells o f P.haemolytica (bovine serum 32 - see section 2.5) was 
analysed for the presence of specific antibodies. This involved immunoblot 
analysis, where the antigen source was Sarkosyl-insoluble OMP preparations of P. 
haemolytica solubilised at different temperatures. The reactivity of the serum 
against P.haemolytica isolates PH188(serotype A l) and PH210 (serotype A2) is 
shown in Figure 15 (lanes 1-6 and 7-12, respectively). A number of findings were 
evident. Firstly, the antibody recognition patterns were different for the two 
isolates. However, this finding has been discussed previously and is due to the two 
distinct OMP types in these two strains (section 3.1). Secondly, no significant 
antibody recognition was demonstrated at the approximate positions of the heat- 
modifiable OMP as indicated by the arrows (lanes 6 and 12). These approximated 
positions for the heat-modifiable OMP are further confiimed and discussed below 
(section 3.2.3.1). Thirdly, the immunoblot profiles of each isolate did not vary 
significantly with the solubilisation temperature, further indicating that no heat- 
modifiable OMP were being recognised. Thus, the heat-modifiable OMP appears 
to be poorly immunogenic in calves in both the low and high molecular weight 
foims. However, a number of other factors could account for these findings and 
these will be discussed later (see section 4.2).
3.2.3.2 Analysis with rabbit monospecific antiserum
In an attempt to raise antibodies specific for the heat-modifiable OMP of P.
haemolytica, the isolated protein (obtained as described in section 2.5.2) was
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Figure 15. Western blot demonstrating the immunogenicity of the heat- 
modifiable OMP using bovine convalescent antiserum 32
Western blot showing the reaction of a 1: 200 dilution of bovine antiserum 32 
against the OMPs of P. haemolytica isolates PH 188 (serotype A l) and PH210 
(serotype A2) in lanes 1-6 and 7-12, respectively, after solubilisation temperatures 
described in Figure 14. Arrows indicate the approximate position of the heat- 
modifiable OMP in both strains. Approximate molecular weights (kDa) are 
indicated on the right.
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injected into rabbits, which were bled at intervals and the antibody response 
examined by Western blotting. There was a low but detectable antibody response 
to the heat-modifiable OMP in the pre-immune serum and a progressive increase 
following immunisation with the protein and boosting, as described in section 
2.5.2. (results not shown). The specificity of this monospecific antiserum for the 
heat-modifiable OMP o f P. haemolytica can be seen in Figure 16 where the serum 
was reacted with OMP preparations (solubilised at 100°C for 20 min) of P. 
haemolytica isolates PFH88 (serotype A l) and PH210 (A2 isolate) (Figure 16a 
and b, respectively, lane 2). These results indicated that although the anti serum 
was raised against the isolated protein from a serotype A l strain, the antibodies 
cross-reacted with the protein of an A2 strain, an indication of the similarities of 
the protein in both serotypes. The results also demonstrated that recognition of 
both molecular weight foims of the protein occurred even though the high 
molecular weight form was used for immunisation.
Direct comparisons of bovine antiserum 32 and the monospecific antiserum 
to the heat-modifiable OMP of P.haemolytica isolates PH 188 and PH220, are 
shown in Figures 16a and b, respectively. In lanes I and 2 of each figure, 
recognition of the antigen by the convalescent (whole-cell) antiserum and the 
monospecific antiserum, respectively, are compared. It is evident that a strong 
antibody response to the heat-modifiable protein of both the A l and A2 isolate 
occurs with the monospecific anti serum but not with the whole-cell antiserum 
(indicated by the arrows). In lane 3 of both figures, the probing antiserum used 
was a mixture of equal parts of both the bovine antiserum 32 and the monospecific 
antiserum, and shows the antibody recognition pattern of the monospecific 
antiserum superimposed on the antibody recognition pattern of the whole-cell 
antiserum. This highlights the positions of the heat-modifiable protein on the latter 
pattern as described in the previous section, 3.2.2, and confirais that bovine 
antiserum 32 did not recognise the heat-modifiable OMP of either of the two 
serotypes.
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16a. Comparison of the reactivity of bovine antiserum 32, rabbit 
monospecific anti-heat modifiable protein serum and a mixture of both, 
against the OMPs of P, haemolyitca  (serotype A l)
Western blot showing reaction of different antisera against the OMPs of P. 
haemolytica isolate PH 188 (serotype A l), solubilised at 100°C for 20 min. The 
antisera used were as follows: 1 in 200 dilution of bovine antiserum 32 (lane 1); 1 
in 2000 dilution of rabbit monospecific anti-heat modifiable protein serum (lane 2); 
and a 1 to 1 mixture of both of the above diluted antisera (lane 3). Arrows indicate 
the position of the heat-modifiable OMP. Molecular weights (kDa) are indicated 
on the right.
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Figure 16b. Comparison of the reactivity of bovine antiserum 32, rabbit 
monospecific anti-heat modifiable protein serum and a mixture o f both, 
against the OMPs of P. haem olyitca  (serotype A2)
Western blot showing reaction of different antisera against the OMPs of P. 
haemolytica isolate PH210 (serotype A2), solubilised at 100°C for 20 min. The 
antisera used were as follows: 1 in 200 dilution of bovine antiserum 32 (lane 1); 1 
in 2000 dilution of rabbit monospecific anti-heat modifiable protein serum (lane 2); 
and a 1:1 mixture of both of the above diluted antisera (lane 3). Arrows indicate 
the position of the heat-modifiable OMP. Molecular weights (kDa) are indicated 
on the right.
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The monospecific anti serum discussed above was also used to demonstrate 
the molecular weight switch, chtiracteristic of the heat-modifiable OMP. In 
Figures 17 and 18, lanes 7-12, the antibody recognition patterns with Sarkosyl- 
insoluble OMP preparations of P H I88 (serotype A l), solubilised at various 
temperatures, are shown. In addimn, Figures 17 and 18 also shows the cross­
reactivity of the antiserum with OMP preparations from E.coli Lilly (lanes 1-6), as 
will be described below (section 3.2.4.1). The difference between these blots was 
due to the anti serum used, i.e., the antiserum used in Figure 17 was antiserum prior 
to cross-absorption with E.coli, whereas the antiserum used in Figure 18 had been 
cross-absorbed with E. coli. Likewise, in Figures 19a and b, respectively, the 
recognition patterns of both the un absorbed and cross-absorbed monospecific sera 
against the OMP preparations of a serotype A2 isolate (PH210) solubilised at 
different temperatures are shown. In Figure 17, significant recognition of the high- 
molecular-weight foiTn o f the heat-modifiable OMP was observed at solubilisation 
temperatures of 85°C and 100°C (lanes 11 and 12, arrow), while recognition of 
the low-molecular-weight form was seen at all temperatures (lanes 7-10). Non­
specific antigen recognition was evident in the low-molecular-weight region 
between 14.4 and 20.1 kDa (lane 8, arrow). However, this was successfully 
removed from the antiserum by cross-absorbing the serum with E. coli (Figure 18, 
lanes 7-12). In contrast to the patterns seen when the cross-absorbed antiserum 
was reacted with PH 188 (serotype Al) ,  where all non-specific antibodies were 
removed (Figure 18, lanes 7-12), non-specific antibodies which cross-reacted with 
isolate PH210 (serotype A2) remained in the antiserum, even after cross- 
absorption with E. coli (Figure 19b, indicated by the arrow), suggesting that 
further cross-absorption, possibly with a different bacterial species is required to 
completely remove these cross-reacting antibodies.
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Figure 17. Western blot demonstrating the immunoreactivity of the heat- 
modifiable OMP of P. haemolytica and E. coli with rabbit monospecific anti- 
heat-modifiable protein antiserum
Western blot showing reaction of a 1 in 2000 dilution of monospecific anti-heat- 
modifiable protein antiserum against the OMPs of E. coli Lilly and P. haemolytica 
isolate PH 188 (serotype A l) in lanes 1-6 and 7-12, respectively, after solubilisation 
at room temperature (lanes 1 and 7), 50°C (lanes 2 and 8), 60°C (lanes 3 and 9), 
70°C  (lanes 4 and 10), 85°C (lanes 5 and 11) for 5 min and 100°C for 20 min 
(lanes 6 and 12). Arrows indicate the heat-modifiable protein in addition to other 
differences (see text). Molecular weights (kDa) are indicated on the right.
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Figure 18. Western blot demonstrating the immunoreactivity of the heat- 
modifiable OMP of P, haemolytica and E.coli with cross-absorbed 
monospecific anti-heat-modifiable protein antiserum
Identical to Figure 17, except the antiserum used had previously been cross­
absorbed with E.coli Lilly as described in section 2.5.3
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19a and b. Western blot demonstrating the immunoreactivity of the heat- 
modifiable OMP of P. haemolytica  isolate PH210 with unabsorbed and cross­
absorbed monospecific anti-heat-modifiable protein antiserum
Western blots showing the reaction of a 1: 2000 dilution of unabsorbed (Figure 
19a) and cross-absorbed (Figure 19b) monospecific anti-heat-modifiable protein 
antiserum against the OMPs of P. haemolytica isolate PH210 after solubilisation at 
room temperature (lanel), 50°C  (lane 2), 60°C (lane 3), 70°C  (lane 4), 85°C 
(lane 5) for 5 min and 100°C (lane 6) for 20 min. Arrows indicate the heat- 
modifiable OMP and other differences (see text). Molecular weights (kDa) are 
indicated on the right.
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Thus, the monospecific antiserum raised in rabbits against the heat- 
modifiable protein isolated from P. haemolytica and absorbed with E.coli proved 
to be specific for the heat-modifiable OMP of both serotypes and was useful for 
further demonstrating the characteristic molecular weight change which occurs in 
this protein. This antiserum was also used in demonstrating the homology of the 
protein of P. haemolytica with proteins in E. coll and other Gram-negative species, 
as described below (section 3.2.4.1).
3.2.4 Comparison of the heat-modifiable OMP of P. haemolytica  with that of 
E.coli and other Gram-negative species
3.2.4.1 W estern Biottting
Previous workers (Beher et al., 1980; Wilson, 1991; Tagawa et a i ,  1993) 
have shown that heat-modifiable OMPs are common in G ram-negative bacteria and 
appear to have very similar properties. The findings reported in this investigation 
demonstrate the similarities of the heat-modifiable OMP of P. haemolytica with 
that of E. coll and other Gram-negative species, fh'st by Western blotting and 
second by N-terminal amino acid sequence.
Figure 17 (lanes 1-6), show the patterns observed when the monospecific
anti-heat-modifiable protein serum is reacted with Sarkosyl-insoluble OMP
preparations of E.coli Lilly solubilised at different temperatures. It was evident
that this anti serum contained antibodies which cross-reacted weakly with the E.coli
heat-modifiable OMP (Fig 17, lanes 1-6) previously visualised by Coomassie blue
staining (Figure 13). To further confirm the presence of cross-reacting antibodies
to the heat-modifiable protein of E. coli in this monospecific antiserum, the serum
was cross-absorbed with E.coli , whereupon no recognition of the heat-modifiable
protein of E.coli was observed (Figure 18, lanes 1-6), although, recognition of the
heat-modifiable protein in P. haemolytica isolates PH 188 and PH210 remained
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(Figure 18, lanes 7-12 and Figure 19b, respectively). Thus, cross-absorbing the 
monospecific antiserum with E. coli removed the cross-reacting antibodies, leaving 
only the P. haemolytica-^^Qoific antibodies.
3.2.4.Z N-terminal amino acid sequencing
In addition to the results obtained above, which have indicated a similarity 
in various properties of the heat-modifiable OMP of P. haemolytica with those in 
E. coli, analysis of the N-terminal amino acid sequence of P.haemolytica  (as 
described in section 2.8) was peifoimed. The results further supported the 
homology of this protein with that in other species. The N-tenninal amino acid 
sequences of the heat-modifiable OMP of a number of Gram-negative species have 
been published (Tagawa et a i ,  1993; Spinola et a i ,  1993) and in Figure 20 the 
homology of these sequences with that found for the P. haemolytica  protein in this 
study is seen. The sequence for the P. haemolytica protein is identical with those 
of Haemophilus somnus and Actinohacillus actinornycetemcomitans, while it 
differs from the E. coli sequence in four amino acids (underlined in Figure 20).
3.3 SERUM SENSITIVITY IN RELATION TO SURFACE PROPERTIES
Twenty two isolates of P. haemolytica were examined for their 
susceptibility to killing by the bactericidal activity of bovine hyperimmune serum 
10. The isolates were chosen to represent those with different capsular types, LPS 
types and OMP types, with the aim of correlating the degree of susceptibility to 
serum killing with these particular properties. This investigation involved a micro­
ti nation plate assay, described previously by Davies (1991), but modified 
accordingly, Preliminai’y experiments were carried out to standardise the 
procedure, prior to its application in screening the different isolates.
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Figure 20. Comparison of the N-terminal amino acid sequence of the heat- 
modifiable OMP of P. haemolytica with those of other Gram-negative species.
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Bacterial species N-terminal amino acid sequence
P. haemolytica A P Q A N T F Y A G A K
E. coli A P K D N T W Y T G A K
Haemophilus somnus A P Q A N T F Y A G A K
Actinobacillus A P Q A N T F Y A G A K
a ctinomycetem corni tans
Adapted from Beher et a i ,  1984; Tagawa et a i ,  1993; and Spinola et a i ,  1993.
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3.3.1 Standardisation of the assay
Before utilising this procedure to screen the different isolates, it was 
important to consider the variable factors which may have had an effect on the 
results and to standardise them accordingly.
Initially, a standard curve of optical density of the P. haemolytica 
suspension against loglO viable count was prepared to enable the adjustment of the 
bacterial inoculum to a known concentration (colony fonning units/ml; cfu ml'^). 
This calibration curve is shown in Figure 21 and was used for all assays. P. 
haemolytica isolate PH8 was used initially, as this proved to be serum-sensitive 
and was a suitable positive control in all future assays. Also, the antiserum source 
used in all assays was antiserum 10 (see section 2.5.1), a hyperimmune anti serum 
raised in calves against P. haemolytica isolate PH2. This antiserum had previously 
been shown by Dr. R. L. Davies to have significant bactericidal activity against 
serum-sensitive isolates. In addition, the serum-sensitive E. coli strain Lilly was 
incorporated into certain assays as another positive control. A further control with 
heat-inactivated serum (treated at 56°C for 30 min) was also used as a negative 
control in all assays.
The factors considered for standardisation of the assay were as follows: the 
concentration of serum in the reaction mixture; the incubation period of the 
reaction; and the size of the bacterial inoculum. Each of these were examined and 
optimised. Figures 22 and 23 demonstrate the killing effect of different 
concentrations of serum on isolate PH8 and E. coli Lilly over a 2 h period. From 
Figure 22 it can be seen that the extent of killing (that is, the decrease in 
log 10 [viable counts]) increased with increasing serum concentration. 
Concentrations of 80 or 90% (v/v) serum resulted in complete killing of the
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Figure 21. Calibration curve for estimating cell numbers - LogjQ viable count 
vs OD610
Pasteurella haemolytica isolate PH 188 was grown in 25 ml BHIB at 37®C, with 
shaking for 4 h. After haivesting (centfrifugation at 3,000 x g for 15 min), the 
bacterial pellet was resuspended in approximately 5 ml of sterile PBS (pH 7.2). 
Six two-fold serial dilutions were performed and the OD610 recorded. Viable 
counts were perfomied, in duplicate, and the mean log 10 viable count calculated 
for each dilution.
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Figure 22. Effect of different incubation periods and serum concentrations 
on the bactericidal activity of serum 10 against P. haemolytica isolate PH8 
and E. coli Lilly
The bactericidal activity of different serum concentrations (as indicated by key in 
figure) against PH8 and E.coli Lilly was assessed at 1 and 2 h.
(C-) in key represents the decomplemented serum control, i.e., serum treated at 
56°C for 30 min.
PH8 alone represents PH8 suspended in PBS (pH 7.2).
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Figure 23. Effect of short incubation periods and serum concentrations on 
the bactericidal activity of serum 10 against P. haemolytica isolate PH8 and 
E.coli Lilly
The experiment was similar to that described in Figure 22 where different serum 
concentrations were examined for bactericidal activity against PH8 and E. coli. 
However, the viability was assessed at 30 and 60 min.
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bacterial cells within 1 h and hence, further incubation using either of these 
concentrations was not required. Heat-inactivated serum at 90% had no effect on 
viable counts and was therefore a satisfactory negative control, while the serum- 
sensitve E. coli Lilly was killed completely within 1 h (Figure 23). In all 
subsequent assays, a serum concenti'ation of 90% was used to ensure that the 
serum was not a limiting factor in the reaction and also because it was more like 
the conditions which actually occur in vivo. Although Figure 22 suggested that an 
incubation period of 1 h was sufficient to produce complete killing o f the bacterial 
inocula, it was of interest to detemiine if a shorter period of incubation would also 
produce complete killing. As shown in Figure 23, the shorter incubation period of 
30 min demonstrated only partial killing of the P. haemolytica even at the higher 
serum concentrations, although serum-sensitive E. coli Lilly was completely killed 
after 30 min. It appeared, therefore, that in order to demonstrate complete killing 
of serum-sensitive P. haemolytica isolates the minimum incubation period required 
was 1 h.
In the above assays, the bacterial inocula consisted of approximately 10^cfu 
in 10 ul of PBS (pH 7.2) added to a final reaction mixture volume of 100 ul to give 
a concentration of 10^ cfu ml'^. However, a comparison of different sized inocula 
in the reaction mixture was performed to determine whether this affected the 
results. This test involved growing P. haemolytica isolate PH8, as described in 
section 2.2.2, harvesting and adjusting the cells to an OD610 of 1.1 in PBS 
(pH7.2), representing approximately 10^ cfu mP^. Ten-fold serial dilutions were 
made to give final concentrations of 10^ cfu mP^, 10^ cfu mP^ and 10^ cfu mP 
The suceptibility of each of these different inocula to the bactericidal activity of 
serum 10, is represented in Figure 24 where the number of viable cells was 
recorded after a 1 h incubation period. The results suggested that the inoculum 
size did not have any significant affect on the final
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Figure 24. Effect of inoculum size on the bactericidal activity of antiserum 10
The bactericidal activity of antiserum 10 was examined with different inocula of P. 
haemolytica in the reaction mixture. Final concentrations of 10^, 10^, 10^, and 
10^ cfu/ml were used (as indicated by key in figure).
(C“) in key represents the decomplemented serum control.
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results. That is, complete killing of the bacteria after an incubation period of 1 h 
was observed, regardless of the inoculum size used. Thus it was decided that the 
highest inoculum would be the standard inoculum for all future assays and would 
give a good range for detecting sensitivity i.e., ranging fiom  0.01 - 100 % 
survivors, a value described in section 2.9.2.
Hence, from these preliminary experiments the assay was standardised to 
use a serum concenti’ation of 90% (v/v), a bacterial concentration of 10^ cfu m l'l 
and an incubation time of 1 h. Such conditions, using isolate PH8 as a positive 
control, would enable the detennination of the serum sensitivity or resistance of a 
large number of isolates in a relatively short period of time with consistency in the 
results obtained.
3.3.2 Serum sensitvity of different isolates of P. haem olytica
The assay was standardised as described above. In each assay, P, 
haemolytica isolate PH8 was included as a positive control together with an 
assessment of the effect of heat-inactivated serum on each isolate tested - 
effectively a negative control.
The range of isolates examined where chosen to represent those possessing 
different capsular, LPS and OMP types as described previously in section 3.1 and 
also by Ali et al. (1992).
The results obtained for the various isolates are shown in Table 5. The definition 
of serum sensitivity or resistance was based on the % survivor value obtained for 
each isolate, i.e., a value >100 % survivors represented serum resistance, a value < 
0.1 % survivors represented a high degree of serum sensitivity and values of 0.1- 
99.9 % survivors represented partial sensitivity. The % survivors observed for the 
control tests, i.e. tests in which heat-inactivated antiserum was used, is given in 
brackets in Table 5, alongside the % survivors
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Table 5. Relationship between serum sensitivity, serotype, LPS and OMP 
type for the 22 P. haemolytica  isolates examined
Bacterial
isolate
serotype LPS
type
OMP
type
% survivors^ Serum
sensitiv
R/S/PS^
PH2 A1 - 152(168) R
PH4 A1 1 - 45.5 (106) PS
PH 162 A1 1 1.1 104 (127) R
PH 164 A1 1 1.2 174 (170) R
PH 180 A1 1 1.2 103 (138) R
PH168 A1 1 1.3 98 (73) PS
PH176 A1 1 1.4 127 (138) R
PH188 A1 1 1.4 234 (361) R
UT3 UT 1 - 101 (111) R
PH26 A1 2 - 95 (400) PS
PH30 A1 2 - 96 (575) PS
PH8 A1 3 - 0.01(400) s
PH48 A1 3 - 0.01(100) s
PH42 A2 3 - 0.07(150) s
PH196 A2 3 2.1 12(403) PS
PH198 A2 3 2.1 12 (107) PS
PH72 A2 4 0.008(50) s
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Table 5. continued...
PH44 A2 5 - 0.04 (292) S
PH202 A2 5 2.2 6(89 ) PS
PH216 A2 5 2.2 0.7 (215) S
PH208 A2 5 2.3 3(50 ) PS
PH214 A2 5 2.4 2(1551 PS
 ^ % survivors calculated using the formula described in section 2.9.2 i.e., cfu/ml at
1 h /  cfu/ml at time 0 x 100. All % survivor results are mean values of duplicate
results. Control results, using heat-inactivated antiserum are indicated in bracket.
= serum resistant; S = serum sensitive; PS = partially serum sensitive, as
defined in section 2.9.2 
UT = untypable
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using the complement-preserved sera. As is evident, a majority of these control 
groups show >  100% survivors, the expected results as the bactericidal activity of 
the serum was destroyed by heat treatment. Although there were some controls 
which actually showed a decrease in cell numbers, the reason for this was not 
entirely clear and requires further investigation. However, these control results 
were particularly useful when interpreting the results observed for the partially 
serum sensitive isolates, PH4, PH26, PH30, PH196, PH198, PH202, PH208 and 
PH214. The values obtained for the controls of these results were significantly 
greater than the actual test, thus indicating that these isolates were sensitive to the 
bactericidal activity of the serum, although to different degrees as seen by the 
range of results from 2% to 98% survivors.
Serum sensitivity or resistance could possibly be related to surface
components such as the capsule (serotype), LPS and the OMP. All o f the serotype
A1 isolates, with the exception of PH8 and PH48, were resistant or partially
sensitive to the bactericidal activity of serum 10 (Table 5), while all isolates of
serotype A2 were serum-sensitive; the untypable isolate, UT3, was serum-resistant.
Significantly, isolate PH2, used for production of the serum 10, was serum-
resistant. Possible reasons why this hyper-immune serum had no bactericidal
activity on the homologous isolate is discussed below (section 4.3). The LPS type
of all the A1 isolates, again, with the exception of PH 8 and PH48 were of the
smooth types 1 or 2. The LPS of isolates PH8 and PH48 was of type 3, a rough
type LPS. This suggests, therefore, that the resistance or sensitivity to the
bactericidal activity o f the serum was correlated to the LPS type, where all isolates
possessing a smooth type LPS (types 1 and 2) were resistant while those with
rough type LPS (type 3, 4, and 5) were sensitive. On the other hand, there was no
indication that variation in serum sensitivity was due to any particular OMP type.
Isolates with OMP types 1.1, 1.2, 1.3 and 1.4 were all resistant to serum killing,
while isolates with OMP types 2.1, 2.2, 2.3 and 2.4 were sensitive. However, as
described in section 3, isolates possessing the former OMP types also possessed
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LPS type 1, a smooth type LPS and thus resistance is likely to be due to this 
property. Likewise the latter OMP types were identified in isolates possessing only 
rough LPS types 3 or 5. Hence, although the property of serum resistance or 
sensitivity is likely to result from a number of factors, this investigation in P. 
haemolytica suggested that this property was associated more so with the LPS 
type of the isolates than with either the serotype or OMP type.
3.4 VIRULENCE TESTS IN CALVES
Investigation of the virulence of P. haemolytica isolates involved 
intratracheal inoculation of calves after three days, the lungs were removed for 
scoring of any pathological changes. Initially the test was standardised with 
respect to the size of the bacterial inoculum and the diluent used. Using the 
optimal conditions detemiined in this part of the study, a number of isolates, 
representing different capsular and LPS types, were compared.
3.4.1 Standardisation of virulence test
Standardisation of the virulence tests involved 21 calves divided into 7 
groups as shown in Table 6 and given different size of i nocula in one of two 
diluents. Two control groups with either diluent alone, were included. Both gave 
satisfactory results, where the mean lesion scores were minimal and significantly 
lower than those seen in the tests in which bacterial cells were included.
Comparing groups 1, 2 and 3, all of which were diluted in PBS but differed 
in the size of the inoculum, an increase is lung lesion scores was evident
Table 6. Standardisation of virulence tests - mean lesion scores compared 
with the different sized inoculum and diluent used
Group Size of inoculum^ Diluent^ Mean lesion scores
1 Low PBS 7.28
2 Medium PBS 19.40
3 High PBS 51.21
4 Low CS 41.28
5 Medium CS 51.76
6* None PBS 0
7* None CS 2.11
^Low inoculum = 2.5 x 10^^  ^ cfu; Medium inoculum = 2.5 x 10^^ cfu; High 
inoculum = 1.25 x 10^^ cfu
^PBS = Phosphate buffered saline (pH 7.4); CS = filter-sterilised culture supernate
* Contol groups
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with an increase in the inoculum size. Likewise in groups 4 and 5 an increase in 
lesion scores was seen between the low and medium inocula. However when the 
two diluents, PBS and filter-sterilised culture supernate, were compared it was 
apparent that the lesions were considerably more extensive with the latter diluent 
than PBS, for a given inoculum. This may have been due to the presence of 
leukotoxin in the culture supernate (discussed in further detailin section 3.4.2).
From this standardisation experiment it was decided that the conditions 
used for group two, i.e., medium inoculum size and diluted in PBS, would be used 
when comparing various isolates. This inoculum was chosen because it was shown 
to produce moderately severe lung lesions but did not result in so many that the 
animal was at risk of being killed. The diluent PBS was chosen to minimise any 
effects which the leukotoxin may have had on the results of the tests as this study 
was mainly concerned with the suiface properties of the bacterium, namely the 
capsule and LPS. However, the importance of the leukotoxin in the vfrulence of 
each isolate was not ignored.
3.4.2 Comparison of virulence of different P. haemolytica  isolates
The virulence of P. haemolytica isolates PH2, PH8, PH 10, PH30, PH42, 
PH44 and PH72 was assessed as described above using a final bacterial inoculum 
of 10 cfu diluted in PBS. Four calves were inoculated with each bacterial strain 
and the mean lesion score for each of the four calves was determined and 
calculated by Dr H. A. Gibbs. The serotype (capsular type) and the LPS type of 
each isolate varied is shown in Table 7 alongside the mean lesion scores 
determined in the virulence tests, the serum sensitivity data (see below) and the 
leukotoxin activity of each isolate (determined by Mr. M. Saadati, Department of
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Table 7. Relationship of lesion score to serotype, LPS type, 
serum resistance and leukotoxin activity
Isolate Serotype LPS type Mean lesion 
scores
Mean bactericidal 
activity 
(% Survivors)
Leukotoxin
activity
PH2 A1 1 8.9 67.1 High
PHIO A1 1 40.5 13.2 High
PH30 A1 2 24.7 120.0 Moderate
PH8 A1 3 1.7 0.0 Moderate
PH42 A2 3 0.5 0.0 Low
PH72 A2 4 0.0 0.0 Low
PH44 A2 5 0.0 0.0 Low
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Microbiology, University of Glasgow, using a neutrophil chemiluminesence assay).
The results indicated that serotype A2 isolates, PH42, PH44, and PH72, 
produced fewer lesions than serotype A1 isolates, with the exception of isolate 
PH8. This latter isolate, although of serotype A l, caused lesion scores which were 
more comparable to those observed for the serotype A2 isolates Serotype A l 
isolates, PH2, and especially PHIO, PH30 produced more extensive lung damage 
(Table 7). This finding suggests that the capsular type could not be directly related 
to the virulence of the isolate unlike other properties, namely the LPS type.
The LPS types of isolates PH2 (LPS type 1), PHIO (LPS type 1) and PH30 
(LPS type 2) were of the smooth chemotype, whereas isolate PH8 possessed LPS 
type 3, which as described previously in section 3.1, was a rough-type LPS. The 
former 3 isolates produced lesion scores significantly higher that PH8 while the 3 
serotype A2 isolates, PH42, PH44 and PH72 possessed LPS types 3, 4 and 5, 
respectively, all of which were of the rough chemotype, and produced lesion scores 
more similar to PH8. These findings suggested a possible correlation of smooth 
type LPS with increased virulence and rough type LPS with avrrulence or low 
lesion scores.
The other data shown in Table 7 indicate the serum sensitivity and the 
leukotoxin activity of the various isolates. The % survivors was the mean value 
from bactericidal assays with each isolate tested in serum from each of the four 
calves into which it was inoculated in the virulence test. The assays were 
performed as described in section 2.9. The findings shown here were similar to 
those reported in section 3.3.2 where isolates which possessed smooth type LPS 
(LPS type 1 and 2) in general appeared to be more resistant to the bactericidal 
activity of the serum than those with rough type LPS (LPS types 3, 4 and 5). 
Thus, in addition to the possible correlation of LPS type with virulence, the result 
above suggested that the ability of the bacterium to resist the bactericidal activity 
of host serum may also be of importance in the overall virulence of the isolate.
The isolates which proved to be avirulent, producing virtually no lesions
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in the virulence tests, were also shown to have low leukotoxin activity whereas 
isolates which caused a greater number of lesions were shown to have moderate or 
high leukotoxin activity, again with the exception of isolate PH8. This isolate, 
although having moderate leukotoxin activity similar to that of isolate PH30, 
caused fewer lung lesions. These isolates, as mentioned previously, differed in 
LPS types, the former possessing LPS type 3 (rough-type) the latter possessing 
LPS type 2 (smooth-type). They also differed in their ability to resist the killing 
activity of host serum, where PH8 was serum sensitive and PH30 resistant to 
serum killing. These findings confimi the importance of other factors, in addition 
to the leukotoxin, in detennining the virulence of each isolate observed in these 
tests.
Overall, this study indicated that the LPS type of the isolate could be 
correlated with the vtiulence of the isolate rather than with the capsular type. 
However, other factors such as serum resistance and leukotoxin activity appear to 
be important.
3.5 IN V E ST IG A TIO N  O F P. H A E M O LYTIC A  G RO W N  IN  VIVO
This investigation was primarily concerned with the growth of P. 
haemolytica in vivo and the differences which may be apparent between in vivo- 
and in vitro-grov/n cells. P. haemolytica isolates PH2, PH30, PH42 and PH48 
were inoculated into intraperitoneal implant chambers (see section 2.11.1) and the 
growth of these isolates within the chambers was followed by daily sampling of the 
chamber contents (see section 2.11.2). Bacteria from the chambers were 
recovered and outer-membrane fractions prepared and analysed by SDS-PAGE 
and Western blotting.
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3.5.1 Growth o f F. haemolytica  in chamber fluid in vivo
Viable counts were performed on samples removed from the chamber over 
a period of 16 days. The growth curves obtained for each of the four isolates were 
similar and thus the curve for isolate PH2 representative of all 4 strains and is 
shown in Figure 25. The initial count at day 1, was approximately 10^ cfu ml"^, 
however this number decreased with time until approximately 10^ cfu ml"^ 
remained when the experiment was terminated on day 16 and the chamber 
removed from the calf (Figure 25). These results suggested that the isolates 
inoculated into the chamber did not multiply, but rather their numbers decreased 
steadily over the period of the experiment. Preliminary investigations were carried 
out in an attempt to understand why the bacterial cells were dying in vivo .
3.5.2 Investigations into the decline in cell numbers within the implant 
chamber
In an attempt to understand why the bacterial cell numbers declined inside
the implant chamber, various experiments were performed. First, the chamber fluid
removed from the four chambers at days 0, 9 and 16 of the experiment were
examined for the ability to kill P. haemolytica in vitro, using the method described
for the bactericidal assays (section 2.9). The chamber fluids, after removal, were
filter-sterilised and stored at -70°C  to remove and preserve any complement
activity which may have been present. The percentage of bacteria surviving in the
chamber fluid after 2 h was calculated as described previously and can be seen in
Table 8. The results indicated that no significant bactericidal activity was present
in any of the chamber fluids which could have accounted for the decline in cell
numbers with the exception of day 16 chamber fluid from chambers inoculated
with PH2 and PH30. The % survivors were generally greater than 100 indicating
bacterial growth, although, the day 16 chamber fluid removed from the chambers
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Figure 25. Growth of P. haemolytica isolate PH2 in vivo in an intraperitoneal 
implant chamber
The survival of the bacteria was examined by removing samples of chamber fluid 
at intervals for viable counts
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inoculated with PH2 and PH30 did cause a small decrease in bacterial numbers 
(see Table 8).
The role of complement activity in the fluid was assessed by incorporating 
decomplemented chamber fluid controls in all assays (results shown in brackets in 
Table 8). The results indicated that the absence of complement activity from the 
chamber fluids did not have a significant effect on the final % survivors but rather, 
produced results relatively similar to those in which complement activity had been 
preserved. This suggested that a complement-mediated killing activity was 
unlikely to be the cause of the decline in bacterial cell numbers.
In addition, the antibody content of the chamber fluids was examined by Western 
blot anlaysis using P. haemolytica (isolate PH2) OMPs as the target antigen. In 
Figure 26, the recognition patterns obtained for each of the four chamber fluids 
from which isolates PH2, PH30, PH42 and PH48 were obtained (Fig 26 a, b, c and 
d respectively) ai*e shown. Chamber fluid removed at days 0, 9 and 16 of the 
experiment are represented in lanes 1 to 3 of each figure. From this figure it is 
evident that the antibody contents in each of the four chamber fluids remained 
virtually the same throughout the period of the experiment and therefore indicates 
that an increase in specific antibody was not the reason for cell death. Further 
investigations are required to understand the reason for bacterial cell death within 
the implant chambers. However, the bacteria which were obtained from the 
chambers as described in section 2.11.4, were representative of in vim -grown cells 
and thus examined by gel electrophoresis,
3.5.3 Comparison of SDS-PAGE OMP profiles of in vivo-grown P. 
haemolytica with those o f in v//m-growii isolates
Oil ter-membrane fractions from each of the isolates from the implant 
chambers were examined by SDS-PAGE. The OMP profiles o f the in viv6>-grown
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Table 8. Effect of chamber ituid on the in vitro growth of P. haemolytica 
isolates PH2, PH30, PH42 and PH48
Isolate % survivors^
day 0 
chamber fluid
day 9 
chamber fluid
day 16 
chamber fluid
PH2 224(223) 153 (153) 82 (244)
PH30 150 (212) 155 (208) 76 (333)
PH42 106 (380) 144 (178) 227 (200)
PH48 651 (233) 108 (60) 216(187)
 ^ Numbers in brackets -  results obtained using decomplemented chamber fluid i. e. 
5 6^ C for 30 min
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Figure 26. Western blot demonstrating the immunoreactivity of P.
haemolytica (PH2) OMPs wih chamber fluid
Western blot showing reaction of a 1 in 200 dilution of chamber fluid, removed 
from chambers into which isolates PH2 (a), PH30 (b), PH42(c), and PH48(d) were 
inoculated, against the OMPs of P. haemolytica PH2. The fluids were removed at 
days 0 (lanes 1), 9 (lanes 2) and 16 (lanes 3).
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isolates, PH2, PH30, PH42 and PH48, on Coomassie blue-stained gels are shown 
in Figure 27a lanes 4 and 12, and 27b lanes 4 and 8, respectively. For comparison, 
the OMP profiles from isolates grown in vitro (Fig 27a lanes 1 and 9, and 27b 
lanes 1 and 5, respectively), or grown in vitro under iron limitation (Fig 27a lanes 2 
and 10 and 27b lanes 2 and 6, respectively) and from isolates obtained from the 
lungs of experimentally-infected calves (Fig 27a lanes 3 and 11, and 27b lanes 3 
and 7) have been included. These latter two groups of OMP fractions were 
provided by Dr. R. L. Davies. Lanes 5 to 8 in Figure 27a show the OMP profiles 
of isolate PHIO where the outer-membrane fractions were again provided by Dr. 
R, L. Davies.
The variation between profiles of each isolate obtained from diffferent sources was 
slight although some differences are indicated by the arrows in Figures 27a and b. 
Variation between isolates grown in vitro and under iron limitation has been 
described previously (Davies et a i ,  1992) and consists of variation in the 
expression of certain proteins in the high-molecular-weight region, particularly the 
77 kDa protein (Fig 27a, lanes 2, 6 and 10) which was more evident in the latter 
profiles. Comparison of the profiles of in v/fra-grown cells with those derived 
from in vivo-grown cells and from cells removed from infected calf lungs has not 
been reported previously.
In Figures 27a and b (lanes 3,4,7,8,11,12 and 3,4,7,8) the OMP profiles of 
the lung derived cells (Fig 27a, lanes 3, 7, 11 and 27b, lanes 3 and 7)and the in 
vivo-grown cells (Fig 27a, lanes 4, 8, 12 and 27b, lanes 4 and 8) appear to be 
similar, although both are different from those of in vitro-grown cells (Fig 27a, 
lanes 1,2,5,6,9,10 and 27b, lanes 1,2,5,6). The variation occurs both in the low- 
molecular-weight region (Fig 27a, lanes 3 and 4; arrows) and the high-molecular- 
weight region. These differences appear to be common in all 5 isolates, where the
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Figures 27a and b. SDS-PAGE OMP profiles of P. haemolytica isolates PH2,
PHIO, PH30, PH42 and PH48, under different growth conditions
Coomassie bliie-stained SDS-PAGE OMP profiles of P. haemolytica isolates PH2 
(Fig 27a, lanes 1-4), PHIO (Fig 27a, lanes 5-8), PH30 (Fig 27a, lanes 9-12), PH42 
(Fig 27b, lanes 1-4) and PH48 (Fig 27b, lanes 5-8) obtained from in vitro-grown 
cells, in vitro-grown cells under iron limitation, lungs from infected calves and 
implant chamber-giown cells in each of the four lanes respectively. Arrows 
indicate differences in OMP profiles (see text). Molecular weight standards (kDa) 
in Fig 27a, lane 13 and Fig 27b, lane 9.
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in vitro-grown cells and cells grown under iron limitation produce profiles which 
although different from each other in some respects, were more significantly 
different from the profiles of in vivo-grown and lung-derived cells. Likewise the in 
vivo-grown cells and those derived from the lungs of infected calves gave profiles 
which were more similar to each other than to the in vitro profiles.
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4. DISCUSSION
4.1 AN EPIDEM IOLOGICAL STUDY OF PASTEVRELLA HAEM OLYTICA
The objectives of this investigation were to examine and compare the OMP and 
LPS profiles of a selection of P. haemolytica isolates of serotypes A1 and A2, 
obtained from both pneumonic and healthy cattle, with the aim o f detecting differences 
and similarities which could prove useful in epidemiological and viiulence studies. The 
OMP and LPS profiles of the 29 isolates examined in SDS-polyacrylamide gels were 
similar to those described in previous studies (Ali et aL, 1992; Davies et a i ,  1992). 
The OMP profiles consisted of three to four major proteins and approximately 1 5 - 2 0  
minor proteins and the LPS profiles were either of the smooth or rough chemotypes. 
Based on variation in the OMP and LPS profiles, the study revealed significant 
heterogeneity both between and within the serotype A1 and A2 isolates. Thus, the 
serotype A1 isolates differed from the serotype A2 isolates in the mobilities of a major 
protein and various minor proteins, as well as in the possession o f smooth as opposed 
to rough LPS. Variation of OMP profiles within the serotype A1 isolates could be 
detected only by Western blotting but variation within serotype A2 isolates was 
detected both in stained gels and by Western blotting. Four distinct OMP types were 
identified within both serotypes by Western blotting, the serotype A2 isolates being 
more clearly differentiated that the serotype A1 isolates. The LPS profiles were 
compared to those described previously (Ali et a i ,  1992) and demonstrated to be of 
smooth type 1 or rough types 3 or 5. The 18 serotype A1 isolates comprised OMP 
types 1.1, 1.2, 1.3 and 1.4 and LPS type 1; the 11 serotype A2 isolates comprised 
OMP types 2.1, 2.2, 2.3 and 2.4 and LPS types 3 and 5.
Previous studies on the OMP profiles of P. haemolytica had not demonstrated 
significant differences either between serotype A1 and A2 isolates or within serotypes. 
In a study of envelope proteins of isolates representing each of the 16 serotypes of P.
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haemolytica, Knights et al. (1990) were unable to distinguish between individual 
serotypes. Deneer and Potter (1989) described variation between serotypes in the 
expression of certain iron-regulated OMPs when cells were grown under iron- 
restricted growth conditions. However, these authors did not observe significant 
differences between serotype A1 and A2 isolates.
The present study has confirmed and extended previous findings that serotype 
A1 and A2 isolates o f P. haemolytica differ in their LPS profiles (Ali et a i ,  1992). It 
has also demonstrated that serotype A1 and A2 isolates differ in the expression of 
various OMPs. However it should be noted that certain similarities also exist between 
some isolates of serotypes A1 and A2. For example, the core-oligosaccharide regions 
of LPS types 1 and 3, which are present in certain serotype A1 and A2 isolates, 
respectively, are identical (Ali et a/., 1992). Type 3 LPS associated with the OMPs of 
serotype A2 isolates of OMP type 2.1/LPS type 3 could account for the enhanced 
imunological staining of the OMP type 2.1 profiles (Fig 10b, lanes 1-3) when 
compared to the OMP types 2.2, 2.3, and 2.4 (Fig 10b, lanes 4-11) which have LPS 
type 5. The primary antiserum was raised against an isolate containing type 1 LPS and 
would therefore contain antibodies to the homologous core region found only in LPS 
types 1 and 3. Such an association between OMPs and LPS in Western blots has been 
described in Pseudomonas aeruginosa by Poxton et al. (1985). The differences 
observed in both the OMP and LPS profiles of isolates of serotypes A1 and A2, as 
well as differences in capsule structure (Adiam et a i ,  1984; 1987) and host specificity, 
suggests that isolates of these two serotypes may not be as closely related as 
previously considered (Frank, 1989). Other work from this laboratory suggests 
that isolates of other biotype A serotypes are more closely related to isolates of 
serotype A1 than those of serotype A2 (Davies, R. L., personal communication).
In the present study, OMP and LPS profiles of P. haemolytica isolates of
serotypes A1 and A2 in stained SDS-polyacrylamide gels were compared and further
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investigations were made by Western blotting. Although SDS-PAGE alone was able 
to differentiate between some isolates of serotype A2, the method was unable to 
discriminate between isolates of serotype A l. Western blotting, however, was able to 
differentiate more clearly between isolates of serotype A2 and was also able to 
distinguish between isolates of serotype A l. Similar findings were reported by 
Mulligan et al. (1988) and Hansman and Lawrence (1993) who found Western 
blotting to have greater resolving power than SDS-PAGE alone in studies on C. 
dijficile and H. influenzae, respectively. It was concluded, therefore, that Western 
blotting is a more useful tool for investigating strain variation within P. haemolytica. 
Although only a single anti serum was used in the present study, this antiserum was still 
able to differentiate between isolates of either serotype. It is likely that the LPS type, 
rather than the serotype, of the isolate used to generate the antiserum will have a 
greater influence on the pattern of protein recognition in Western blots for reasons 
discussed above. LPS analysis alone was found to be less discriminating than OMP 
analysis. However, since various LPS types occur within serotype A l and A2 isolates 
of P. haemolytica (Ali et al., 1992) it is important that LPS analysis should be 
included in future epidemiological studies of this speices.
On the basis of differences detected in OMP and LPS profiles, the present 
study has demonstrated that serotype A l and A2 populations of P. haemolytica are 
more diverse than previously thought. In addition, the study has provided evidence to 
suggest that these differences may be useful in epidemiological studies. For example, 
the serotype A l isolates from famis 1, 2, 3 and 4 could be distinguished in temis of 
their OMP types even though the differences were slight. Isolates obtained from farm 
5 on three separate occasions could be distinguished in terms of their serotype, OMP 
type and LPS types. Although the number of isolates in the present study was 
relatively small, the examples described above nevertheless demonstrate that
differences in the OMP and LPS profiles of serotype A l and A2 isolates of P.
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haemolytica  do occur, and that this variation can be detected by the methods 
described. Although there was no clear correlation of a particular OMP or LPS type 
with virulence in the isolates examined, with the possible exception of serotype A2 
isolates of OMP type 2.1/LPS type 3, future investigations on a larger number of 
isolates may be useful in demonstrating such a relationship.
4.2 CHARACTERISATION OF A HEAT-M ODIFIABLE OM P IN P, 
H A E M O LYTIC A
Heat-modifiable proteins have been described in a variety of Gram-negative 
bacteria, including E. coli (Beher et a i ,  1980), and more recently in H. somnus 
(Tagawa et a i ,  1993), H. ducreyi (Spinola et al., 1993) and A. 
actinomycetemcomitans (Wilson, 1991). The latter three spe-des are all members of 
the family Pasteurellaceae. Nakamuru & Mizushima (1976) described the property of 
heat-modifiablity and related the phenomenon to the stiiictural confiimation of the 
protein at different solubilisation temperatures, i.e. at higher solubilisation 
temperatures the protein is predominantly alpha-helical, binding less SDS and 
consequently running slower on SDS-polyacrylamide gels. Conversely, at lower 
temperatures, beta-sheets predominate, binding more SDS and running more quickly 
on gels. Thus at lower temperatures, the low-molecular-weight form of the protein 
was visualised and vice versa.
This report was concerned with the characterisation of a heat-modifiable outer-
membrane protein in P. haemolytica and comparing it with those previously reported
in other Gram-negative species. Several lines of evidence from this investigation
indicate that the species P. haemolytica does possess a heat-modifiable protein which
is similar to the Omp A protein found in E . coli and to heat-modifiable proteins in
other species. Firstly, the molecular mass of the heat-modifiable protein of P.
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haemolytica and the characteristic shift from a low to a high molecular weight at 
higher solubilisation temperatures resembles the findings obsei*ved for E. coli Lilly in 
this study and also the findings previously reported for other bacterial species (Beher 
et ah, 1980; Wilson, 1991; Spinola et al., 1993; Tagawa et al., 1993). Secondly, the 
immunological cross-reactivity of rabbit monospecific antiserum raised against the 
39.5 kDa protein of P. haemolytica with the heat-modifiable protein of E. coli, 
indicates the possession of similar epitopes. Thirdly, the N-temiinal amino acid 
sequence of the 39.5 kDa protein of P. haemolytica, determined in this 
investigation,was closely homologous to those of other bacterial species, not only in 
the same family Pasteurellaceae {H. somnus, H, ducreyi and A. 
actinomycetemcomitans) but also in the Enterobactericeae, such as E. coli.
The presence of heat-modifiable proteins in P. haemolytica and E. coli Lilly 
was demonstrated firstly by SDS-PAGE analysis of outer-membrane fractions of each 
species and secondly by Western Blotting with rabbit monospecific antiserum. The 
molecular weights of the high- and low-molecular weight fomis of the heat-modifiable 
protein in each species were 31 and 39.5 kDa and 30 and 33kDa, respectively. This 
difference in the molecular weights between the two species is not surprising as Beher 
et al. (1980) studied the heat-modifiable protein of many bacterial species and showed 
that variation did exist, although the range of molecular weights was generally 
between 27 and 42 kDa. The high-molecular-weight forms of the heat-modifiable 
proteins of H. somnus and A. actinomycetemcomitans were 37 and 34 kDa, as 
reported by Tagawa et al. (1993) and Wilson (1991), respectively. The conclusion 
from this section was that the 39.5 kDa protein of P. haemolytica  was the heat- 
modifiable Omp A-like protein, a protein common to other Gram-negative species.
The immunogenicity of this P. haemolytica protein was assessed. Using a
bovine convalescent antiserum raised against strain PH2, the he at-modifiable protein
of both serotype A 1 and A2 isolates was shown to be unrecognized by the antibodies
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present in this antiserum as observed in Western blots. However, in contrast to this 
finding, a rabbit monospecific anti serum raised against the isolated 39.5 kDa protein of 
P. haemolytica demonstrated a high immunoreactivity with the heat-modifiable 
protein. These findings could suggest that the heat-modifiable protein, when present 
on the surface of intact cells, is less immunogenic than the isolated protein. In the 
intact cell, other bacterial surface components may conceal the heat-modifiable protein 
in such a way that it is unable to induce the production of specific antibodies and is 
therefore poorly immunogenic. It is also possible that the native form of the protein in 
the intact cells does induce antibodies but which are unable to recognise the denatured 
forni of the protein present in SDS-polyacrylamide gels. Alternatively, this protein 
may be less immunogenic in calves than in rabbits due to a resemblance to a bovine 
protein and it would therefore not be recognised as a foreign antigen.
In contrast, Tagawa et al. 1993 and Spinola et al. 1993, showed the heat- 
modifiable proteins of H. somnus and H. ducreyi, respectively, to be significantly 
immunogenic. These workers also used convalescent sera. Thus, further studies are 
required to understand the reasons behind the apparent non - i mmunogenici ty of the 
heat-modifiable protein of P. haemolytica in the natural host species.
The monospecific antiserum raised against the isolated 39.5 kDa protein, was
also useful in demonstrating the cross-reactivity of the heat-modifiable protein of P.
haemolytica serotype Al isolates with a similar protein in serotype A2 isolates of P.
haemolytica and also in E. coli. This cross-reactivity was not surprising as the heat-
modifiable proteins found in many Gram-negative species show considerable
homology (Beher et al., 1980). In this report the cross-reactivity was demonstrated
by Western blotting. The monospecific antiserum was able to recognise the heat-
modifiable protein of all P. haemolytica strains tested of either A l or A2 serotype.
Unfortunately, time did not pennit further studies of this similarity. Such studies might
have involved cross-absorbing the antiserum with whole-cells of each serotype and re-
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examining the extent of antibody recognition which remained. However this type of 
examination was performed using antiserum cross-absorbed with E. coli antisemm. 
The results demonstrated that the cross-absorption removed all E. co/i-specific 
antibodies but did leave antibodies which recognised the P. haemolytica protein. This 
indicated that although the proteins of both these species were homologous to some 
degree, there were distinct epitopes on the P. haemolytica protein which were not 
present in the E. coli protein. This finding was particularly interesting when the N- 
terminal amino acid sequences were studied.
The N-terminal amino acid sequence of the 39.5 kDa protein of P. haemolytica 
was detemiined in this investigation. Comparisons were made with the sequences 
previously reported for the Omp A protein of E. coli, the 37 kDa heat-modifiable 
protein of H. somnus (Tagawa et al., 1993) and the 34 kDa protein of A. 
actinomycetemcomitans (Wilson, 1991). The latter two species belong to the same 
family as P. haemolytica. Comparisons of the first twelve amino acids of the N- 
termini of the protein revealed that those of P. haemolytica, H. somnus and A. 
actinomycetemcomitans were identical whereas the E.coli sequence differed in four 
amino acids. This finding agreed with the work of Beher et al. (1980) who reported 
that although most Gram-negative species possess an Omp A-like protein, chemical 
comparisons of the proteins indicated that their primary structures differed in 
relationship to their phylogenetic position.
In summary, this part o f the study demonstrated that a major 39.5 kDa heat-
modifiable OMP of P. haemolytica was common to both serotype A l and A2 isolates
and was simiUa to the Omp A protein of E. coli both immunologically. The protein of
P. haemolytica was shown in this study to be poorly immunogenic in cattle when
present in intact cells but was highly immunogenic in rabbits in the isolated fonn. The
P. haemolytica heat-modifiable protein appeared to be more closely related to those
from species belonging to the same family than to a protein from E. coli, as was
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evident from the sequence data.
The Omp A protein of E. coli has previously been shown to confer stability on 
the outer-membrane (Sonntag et a i ,  1978), has been recognised as a surface receptor 
for certain bacteriophages (Van Alphen et al., 1977) and, more recently, its association 
with serum resistance and pathogenicity have been reported (Weiser & Gotschlich, 
1991). This report has identified the heat-modifiable protein of P. haemolytica and 
assessed its immunogenicity and similarities with the heat-modifiable proteins of other 
species. Purification and isolation of the protein and detennination of the exact 
functions of the protein is now required and should be the focus of future 
investigation. This will ultimately lead to a greater understanding of the role of this 
OMP in pathogenesis and will also determine whether this antigen should be 
considered in future Pasteurella vaccine development studies .
4.3 SERUM SENSITIVITY IN RELATION TO SURFACE PROPERTIES
The bactericidal action of complement, found in extracellular fluids and serum,
is an important host defence mechanism against Gram-negative bacteria (Taylor, 1983;
Joiner et al., 1984; Crokaert et al., 1992). The proteins which constitute the
complement system, after activation by the alternative or classical pathway, form a
membrane-attack-complex which ultimately leads to lysis of bacterial cells. The ability
of bacteria to resist complement killing is an important virulence attribute and may
allow multiplication of the bacteria inside its host species (Taylor, 1983). This
property of complement resistance has been documented in a number of Gram-
negative species (Schneider, 1985; Kim et al., 1986; R y croft & Cullen, 1990),
although its basis may be multifactorial (Crokaert et al., 1992). Surface components
of bacterial cells, namely capsular polysacchai*ides (Kim et al., 1986; Cross et al.,
1986), LPS (Cross et al., 1986; Grossman et al, 1987; Merino et al., 1992) and OMPs
109
(Blaser et al, 1987; Weiser & Gotschlich, 1990) have been associated with resistance 
to killing by host serum and have been investigated in many species including E. coli. 
Neisseria  species and Actinobacillus pleur op neumoniae.
The study of complement bactericidal activity against P. haemolytica  to date 
has been limited, although the work of MacDonald et al. (1983) and Sutherland
(1988) demonstrated that P. haemolytica isolates were susceptible to the Classical 
pathway of complement-mediated killing by bovine serum. Both of these groups of 
workers showed that killing of the bacteria was observed only when bactericidal 
antibodies were p resen t, i.e., complement alone was ineffective.
This study set out to identify strains of P. haemolytica which were resistant to 
killing by the Classical complement pathway and attempt to correlate this resistance 
with the various surface components of the bacteria. Twenty two P. haemolytica 
isolates, differing in their capsular, LPS and OMP types, were examined for sensitivity 
or resistance to the bactericidal activity of bovine hyperimmune antiserum 10 which 
has been raised against P. haemolytica isolate PH2. The assay used was an adaptation 
of that of Davies (1991) and was standardised for the purpose of this study. A serum 
concentration of 90% (v/v) of the total reaction mixture was used, an initial inoculum 
of 10^ cfu in a final volume of 100 ul and an incubation period of 1 h were the 
standard conditions for all assays. The % survivors was calculated for each isolate. 
Of the 22 isolates examined, seven proved resistant to serum killing, six were highly 
sensitive to serum killing while the remaining nine were designated partially sensitive. 
These designations were based on the values >100 % survivors, <0.1 % survivors and 
0.1-99.9 % survivors, respectively.
In this assay, the isolate to which the hyperimmune serum was raised, PH2,
proved to be resistant to the bactericidal activity of the serum. This finding was
unexpected as it suggested that no bactericidal antibodies were present in the serum.
However, a similar result has been reported by R y croft & Cullen (1990) for the
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porcine pathogen Actinobacillus pleuropneumonieae and these workers proposed that 
this finding was due to the presence of blocking antibodies in the serum. Such 
antibodies have been described in relation to other species (Corbiel et al., 1988; Rice 
& Kasper, 1982). This phenom e^non is thought to involve the binding of IgG type 
antibodies to the bacterial cell surface at sites which prevent the binding o f IgM 
antibodies which are thought to be more efficient bactericidal antibodies (Taylor, 
1983), thus inhibiting the Classical complement-mediated lysis of the bacteria. This 
explanation does not suffice for the results of this study, as other isolates of P. 
haemolytica were successfully killed by this serum.
In addition to isolate PH2, six other isolates proved to be resistant to the
bactericidal activity of bovine serum and all seven were of serotype A l and possessed
LPS type 1. These findings, alone, did not prove very useful in determining the basis of
serum resistance in P. haemolytica. However, when the capsular, LPS and OMP
types of these serum resistant isolates were compared with those of the serum sensitive
isolates, a number of conclusions could be ch'awn. The six isolates which were highly
serum sensitive were either of serotype Al (two isolates) or serotype A2 (four
isolates). Three different LPS types were found amongst these isolates, LPS 3, 4 or 5
(three, two and one isolates, respectively). Contrary to previous reports in E. coli
(Kim et al., 1986; Cross et al., 1986) where certain capsular types were found only in
serum resistant strains, there was no clear correlation between capsular type and serum
resisitance in P. haemolytica. On the other hand a more definitive association of LPS
types with serum resistance could be made. LPS type 1, found in all serum resistant
isolates was of the smooth foim whereas LPS types 3, 4 and 5 were all rough type
LPS and found only in serum sensitive isolates. This association of serum resistance
with smooth fonms of LPS has been described previously (Muschel & Larsen, 1970;
Schneider et al., 1982; Grossman et al, 1987), although not in P. haemolytica. Two
mechanisms by which smooth type LPS confer resistance have been proposed. Firstly
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the long polysaccharide chains present on smooth forms of LPS bind the antibodies 
which initiate the complement cascade at sites too far from the bacterial membrane to 
allow insertion of the membrane-attack-complex. Thus, lysis does not take place. 
Secondly, the extended LPS structures may mask potential antigens found on the 
surface o f the bacteria to which the bactericidal antibodies were produced. Therefore 
it may be that in P. haemolytica the smooth type LPS found in all serum resistant 
strains is conferring resistance by one or both of the mechanisms above.
The role o f OMPs in serum resistance has been described in E. coli (Weiser & 
Gotschlich, 1990) and also in Campylobacter jejuni (Blaser et a i ,  1987). In P. 
haemolytica their role is not clear. Although isolates possessing the different OMP 
types were examined, no definite conclusions could be drawn. OMP types 1.1, 1.2, 
and 1.4 were associated with smooth type LPS and found in serum resistant isolates 
only, whereas OMP types 2.1, 2.2, 2.3 and 2.4, associated with rough fomis of LPS, 
were present in serum sensitive isolates. Thus it seems that the important determinant 
of serum resistance in P. haemolytica, is the LPS, although OMPs may have a role 
which remains to be defined.
In this study, nine of the 22 isolates were designated partially serum sensitive. 
These isolates, although grouped together, differed quite significantly in the 
percentage of survivors after incubation. The values ranged from 2 to 98 % and in 
some cases, particularly those isolates which had a % survivor value of >90 %, it may 
be that the isolates are resistant when one allows for viable counting errors. 
Therefore, in considering three of the serotype A l isolates which possessed LPS type 
1 (smooth type LPS) and had % survivor values of 95, 96 and 98 it is possible that 
these isolates were in fact serum resistant. Further assays with greater replication 
would help to clarify this situation.
In this investigation, serum resistant isolates of P. haemolytica were identified.
No definite relationship was observed between capsular or OMP type and serum
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resistance, but a correlation of smooth type LPS with resistance was seen. The 
importance of complement resistance in P. haemolytica infections is not clear. 
Pasteurella haemolytica is, primaiily, respiratoiy/ pathogen. The alveolar 
macrophages are thought to be the most important line of defence in the lower 
respiratory tractbut, it is known that P. haemolytica secretes a potent leukotoxin 
which can destroy these immune effector cells (Lo, 1990). Under these cii’cumstances, 
host defences such as the complement cascade are likely to be important. Thus, 
resistance to the bactericidal activity of complement would promote survival and 
colonisation of the respiratory tract under such conditions.
Resistance of bacteria to complement killing is often related to their 
involvement in septicaemic infections. Isolate PH2, however, and the other bovine 
isolates of P. haemolytica which are serum resistant are not known to cause a 
septicaemia infection but rather cause a localised pneumonia. Possibly the resistance 
to complement killing is a property which is of importance in later stages of the lung 
disease. The increasing production of the leukotoxin destroys a greater number of the 
macrophages and consequently the humoral immunity becomes increasingly important. 
Also, the release of indammatory mediators at the site of infection may cause an influx 
of serum components including antibodies and complement proteins into the alveoli 
thus facilitating this humoral immunity. However, it is evident that to fully understand 
the basis of complement resistance in P. haemolytica and its importance in 
pathogenesis, further investigations are required.
4.4 V IR U L EN C E TESTS IN CALVES
In this part of the investigation the ability of a number of isolates to cause lung
lesions following intratracheal inoculation was assessed. This property was taken to
be indicative of the virulence of the strain. The isolates examined were chosen to
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represent those with different capsular and LPS types, in an attempt to correlate 
various types of surface antigens with virulence.
The initial stage of this investigation involved standardisation of the conditions 
of the tests in tenns o f the inoculum and the effect of different diluents. When filter- 
sterilised culture supernate was the diluent, a significantly higher number of lesion 
scores were observed than when sterile PBS was used. This suggested that there was 
a component present in the culture supernate which may be involved in producing lung 
lesions. It may have been due to P. haemolytica leukotoxin in the culture supernate 
which is itself capable of causing lung lesions (Gibbs et al., 1984) or to the presence of 
LPS. It was decided therefore that sterile PBS would be used when comparing the 
various isolates so as to avoid any interference which may occur due to leukotoxin or 
LPS presence.
The inoculum size suitable for the virulence tests was that which gave 
significant lesions which were reproducible and countable but also would not create a 
risk of killing the animal. The medium-sized inoculum, approximately 2.5 x 10^^ cfu, 
was chosen as it fulfilled the above requirements. Thus a final inoculum of the above 
size diluted in sterile 20 ml PBS were the standard conditions applied to the 
comparative virulence tests.
In these tests a number of isolates differing in serotype (capsular type) and 
LPS type were examined. Other features of each of the isolates, namely the ability to 
resist the bactericidal activity of serum and the leukotoxin activity were determined 
and the results incorporated into this study. Similar studies have been reported in 
other bacterial species where an association was shown between specific capsular 
antigens (Achtman et a i ,  1983; Kim et a i ,  1986), LPS types (Cross et al., 1986), 
serum resistance (Pai & DeStephano, 1982; Davies, 1991) and virulence. In this 
present study the aim was to identify any such properties which correlated with 
virulent P. haemolytica isolates.
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No clear-cut association of capsular type with virulence was detected although 
a correlation of LPS type with virulent strains was shown. That is, isolates with 
smooth-type LPS appeared to be more virulent than those with rough-type LPS, 
producing a higher number of lesions in the virulence tests. Similar findings, where 
smooth-type LPS was associated with increased virulence, have also been reported for 
other bacterial species (Achtman et al., 1983; Lugtenberg et al., 1984), namely E. coli 
and P. multocida, respectively. However as the virulence of a bacterium is known to 
be multifactorial, other factors in addition to LPS are likely to be contributing to the 
results observed in these virulence tests.
Serum resistance and leukotoxin activity of the isolates were considered. The 
results of the bactericidal assays indicated that serum sensitivity could somewhat be 
correlated with a high mean lesion score. As previously reported, however, smooth- 
type LPS seems to be associated with serum resistance (Cross et al., 1986; Grossman 
et al., 1987; Merino et al., 1992). Thus, the importance of LPS in virulence is further 
stressed.
As for the leukotoxin, this virulence detemiinant is known to be one of the 
most important factors in P. haemolytica pathogenicity and thus the inclusion of the 
leukotoxin data for each of the isolates was particulaily important even though this 
investigation was concerned primarily with the surface structures of the bacterium. 
The results indicated that, in general, isolates which produced low levels of leukotoxin 
also produced low lesion scores. However, comparison of two isolates, namely, PH 8 
and PH30, both of which produce medium levels of leukotoxin, showed that other 
factors were important in determining the results of the virulence tests as they differed 
significantly in the level of lesions produced.
In summary, this line of the investigation, did provide strong evidence for 
taking account of detemiinants such as LPS type and serum resistance properties in
studies of virulence mechanisms of P. haemolytica.
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4.5 IN V E ST IG A TIO N S OF P. H A E M O LYTIC A  G RO W N  IN  VIVO
Tissue chamber implants in the peritoneal cavity have been used for some 
time to study the in vivo characteristics of bacteria (Finn et al., 1982; Kelly et al., 
1989; Trees et al., 1991). Previous investigations of P. haemolytica grown in implant 
chambers have been limited (Morck et al., 1991; Confer et a i ,  1992) and thus the in 
vivo characteristics of this species are not completely understood.
In this study, the growth of four P. haemolytica isolates (PH2, PH30, PH42 
and PH48) in intraperitoneal implant chambers was assessed. Organisms recovered 
from the chambers were used for studying variations between OMP profiles of in vitro 
and in v/vo-grown cells; LPS profiles of the in vivo organisms, unfortunately, were not 
examined due to time limitation and also a lack of bacterial samples for perfomiing the 
LPS extractions.
Initially, however, the growth of the organisms within the chambers was
examined. Contrary to the findings of Confer et al. (1992) where the bacteria grew
successfully inside the chambers inserted into the para!umbar fossa of calves, this
investigation reported a decrease in the bacterial numbers, a finding similar to the
report of Morck et al (1991) who also saw a decline in bacterial cell number in
chambers inserted into sheep. In this present study the initial inoculum of
approximately 10^ cfu mf^ decreased to 10“^ cfu mf^ during the 16 days of the
experiment. Similarly, Morck et al. (1991) reported a decline from 10^ cfu m f * to 10^
cfu ml"  ^ over a 14 day period. These findings differ from those with other bacterial
species (Finn et al., 1982; Kelly et a i ,  1987; Trees et a i ,  1991), namely, E. coli.
Pseudomonas aeruginosa, and Haemophilus ducreyi, respectively, where successful
growth of the bacteria within the chambers was reported. However Onderdonk et al.
(1989) showed a decline of 10^ cfu ml"  ^ to zero when Bacteroides fragilis  was
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inoculated into the implant chambers inserted into the peritoneal cavity of of mice. A 
number of experiments were performed in an attempt to understand the decline of P. 
haemolytica within the chambers.
The results indicated that there was no change in the level o f P. haemolytica 
specific antibodies to OMPs in the chamber fluid during the 16 days o f the experiment 
and also that complement activity was not important for the decline in cell numbers 
within the chamber; this possibly suggested that an antibody-dependent complement- 
mediated killing mechanism was not occurring inside the chamber. The report of 
Onderdonk et al. (1989) also supported an antibody-complement independent 
mechanism of bacterial killing and they suggested that a cellulai’ immune response was 
the most likely reason for the decline in cell numbers. The role of a cellular immune 
response in the killing of P. haemolytica within the chamber should be considered in 
future in vivo studies of P. haemolytica.
Although the cell numbers were relatively low at the end of the experiment, a 
sufficient number of cells were rescued for outer-membrane preparations, as described 
previously in section 2.11.4. Examinations of the OMP SDS-PAGE profiles and 
comparison with OMP profiles obtained from the same isolates grown in vitro and 
derived from the lungs of P. haemolytica-'mftoied calves were made. A number of 
differences were detected although they were slight and their is unknown.
The high-molecular-weight proteins, 71, 77 and 100 kDa, previously reported 
in in v/vo-grown cells (Morck et a i ,  1991) and in cells grown in vitro under iron 
limitation (Donachie & Gilmour, 1988; Deneer & Potter, 1989; Davies et al., 1992), 
were also detected in the bacteria which had been grown inside the implant chamber. 
In addition, the differences in the low-molecular-weight region of the profiles detected 
in this report were similar to those reported by Confer et al. (1992) who detected 
differences in the region < 30 kDa in the profiles of in vivo and in vitro-gvown cells.
The importance of these differences remains to be investigated.
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Some of the differences between in vitro- and in vivo-grown cells may be due 
to contaminating host proteins as was previously discussed by Finn et al. (1982). They 
suggested that host immunoglobulins may contribute to the profiles of the in vivo- 
grown cells. However, to determine the origin of the extra proteins in the in vivo- 
grown P. haemolytica cells, further studies would be required. Nevertheless, the 
results have highlighted some of the changes in bacterial properties which can occur 
when bacteria are grown in vivo. In addition they have stressed the importance of 
considering the results o f in vivo studies when interpreting the in vitro studies of 
pathogenic features of bacteria.
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APPENDICES
APPENDIX 1 - Reagents used in SDS-PAGE
SAMPLE BUFFER: X I X2
0 .5M  Tris-HCl (pH6.8) 5 ml 5 ml
glycerol 4 ml 4 ml
10%SDS 8 ml 8 ml
2-beta-mercaptoethanol 2 ml 2 ml
0.05% bromophenol blue 1 ml 1 ml
distilled water 20ml
STACKING GEL:
0.5M Tris-HCl (pH6.8) 5.0 ml
10%SDS 0.2 ml
Acrylamide/bisacrylamide 2.6 ml
(30& T. 2.6%C)
distilled water 12.2 ml
10%ammonium persulphate 0.1 ml
TEMED 0.02 ml
RESOLVING GEL:
12% acrylamide (for OMP SDS-PAGE):
1.5M Tris-HCl (pH 8.8) 15.0 ml
10% SDS 0.6 ml
Acrylamide/bis,acrylamide 24.0 ml
distilled water 20.1 ml
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l()%ammonium persulphate 0.3 ml
TEMED 0.03 ml
10% (for tricine gel electrophoresis):
Gel buffer 19.8 ml
(3M Tris, 0.3% SDS) 
Acrylamide/bisacrylamide 12.0 ml
(48%T, 1.5% C)
glycero 16.0 ml
distilled water 22.2 ml
10%ammonium persulphate 0.45 ml
TEMED 0.045 ml
15% aery I amide/4 M urea (for EPS SDS-PAGE):
1.5M Tris-HCl (pH8.8) 15.0 ml
10% SDS 0.6 ml
Acrylamide/bisacrylamide 30.0 ml
Urea 14.4 g
RESERVOIR BUFFER:
Trizma base 13.5 g
Glycine 64.8 g
SDS 4.5 g
distilled water 4500 ml
CATHODE BUFFER (for tricine SDS-PAGE):
Trizma base 12.11 g
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Tricine 17.92 g
SDS 1.00 g
distilled water 4000 ml
ANODE BUFFER (for tricine SDS-PAGE):
Trizma base 96.88 g
distilled water 4000 ml
COOMASSIE BLUE STAIN:
Methanol 450 ml
Acetic acid 100 ml
Coomassie blue 1.00 g
distilled water 450 ml
DESTAIN:
Methanol 300 ml
Acetic acid 100 ml
distilled water 600 ml
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APPENDIX 2 - Reagents used for silver staining of EPS
FIXING SOLUTION:
ethanol 400 ml
acetic acid 50 ml
distilled water 550 ml
FIXING SOLUTION + 0.7% PERIODIC ACID:
fixing solution 400 ml
periodic acid 2.8 g
STAINING REAGENT:
O.IM sodium hydroxide 56 ml
ammonium hydroxide 4 ml
20% silver nitrate 10 ml
distilled water 230 ml
FORMALDEHYDE DEVELOPER:
5% citi’ic acid 2.0 ml
37% formaldehyde 0.2 ml
distilled water 400 ml
50% METHANOL:
methanol 500 ml
distilled water 500 ml
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APPENDIX 3 - Reagents used for Western blotting
TRANSFER BUFFER:
Trizma base 12.12 g
Glycine 57.60 g
distilled water 4000 ml
TRIS BUFFERED SALINE (TBS, pH7.5):
Sodium chloride 58.44 g
Trizma base 4.84 g
Distilled water 2000 ml
TBS +0.05% TWEEN 20 (TTBS, pH7.5):
TBS 1000 ml
Tween 20 0.5 ml
BLOCKING SOLUTION;
TBS 100 ml
Gelatin 3.0 g
ANTIBODY BUFFER:
TTBS 200 ml
Gelatin 2.0 g
COLOUR DEVELOPM ENT SOLUTION:
4-CH LO RO -1 -NAPTHOL:
4-chloro-l-napthol 60 mg
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methanol 20 ml
TBS 100 ml
hydrogen peroxide 0.06 mi
> BENZOIC ACID (DAB):
PBS 100 ml
DAB 30 mg
1 % cobalt chloride 2 ml
hydrogen peroxide 100 111
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